Frequencies for first 10,000 rows of pt variable in reac2010q1 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- 5Q MINUS SYNDROME | 1 0.01 0.01 ABASIA | 18 0.18 0.19 ABDOMINAL ADHESIONS | 1 0.01 0.20 ABDOMINAL COMPARTMENT SYNDROME | 1 0.01 0.21 ABDOMINAL DISCOMFORT | 16 0.16 0.37 ABDOMINAL DISTENSION | 21 0.21 0.58 ABDOMINAL HERNIA | 2 0.02 0.60 ABDOMINAL NEOPLASM | 1 0.01 0.61 ABDOMINAL PAIN | 61 0.61 1.22 ABDOMINAL PAIN LOWER | 9 0.09 1.31 ABDOMINAL PAIN UPPER | 46 0.46 1.77 ABNORMAL BEHAVIOUR | 19 0.19 1.96 ABNORMAL DREAMS | 4 0.04 2.00 ABNORMAL FAECES | 2 0.02 2.02 ABNORMAL LOSS OF WEIGHT | 1 0.01 2.03 ABNORMAL SENSATION IN EYE | 1 0.01 2.04 ABORTION | 1 0.01 2.05 ABORTION INDUCED | 3 0.03 2.08 ABORTION SPONTANEOUS | 18 0.18 2.26 ABORTION THREATENED | 1 0.01 2.27 ABSCESS | 6 0.06 2.33 ABSCESS DRAINAGE | 2 0.02 2.35 ABSCESS NECK | 1 0.01 2.36 ACCIDENT | 2 0.02 2.38 ACCIDENTAL DRUG INTAKE BY CHILD | 1 0.01 2.39 ACCIDENTAL EXPOSURE | 2 0.02 2.41 ACCIDENTAL OVERDOSE | 6 0.06 2.47 ACCOMMODATION DISORDER | 2 0.02 2.49 ACIDOSIS | 2 0.02 2.51 ACNE | 3 0.03 2.54 ACQUIRED HAEMOPHILIA | 1 0.01 2.55 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 1 0.01 2.56 ACTIVATION SYNDROME | 1 0.01 2.57 ACTIVITIES OF DAILY LIVING IMPAIRED | 9 0.09 2.66 ACUTE ABDOMEN | 1 0.01 2.67 ACUTE CORONARY SYNDROME | 2 0.02 2.69 ACUTE DISSEMINATED ENCEPHALOMYELITIS | 1 0.01 2.70 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN | 1 0.01 2.71 ACUTE HEPATIC FAILURE | 2 0.02 2.73 ACUTE INTERSTITIAL PNEUMONITIS | 1 0.01 2.74 ACUTE LEUKAEMIA | 1 0.01 2.75 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT | 1 0.01 2.76 ACUTE MYELOID LEUKAEMIA | 4 0.04 2.80 ACUTE MYOCARDIAL INFARCTION | 5 0.05 2.85 ACUTE PHASE REACTION | 1 0.01 2.86 ACUTE PSYCHOSIS | 1 0.01 2.87 ACUTE PULMONARY OEDEMA | 2 0.02 2.89 ACUTE RESPIRATORY DISTRESS SYNDROME | 6 0.06 2.95 ACUTE RESPIRATORY FAILURE | 6 0.06 3.01 ACUTE TONSILLITIS | 1 0.01 3.02 ADENOCARCINOMA | 1 0.01 3.03 ADENOMYOSIS | 2 0.02 3.05 ADNEXA UTERI PAIN | 1 0.01 3.06 ADRENAL DISORDER | 1 0.01 3.07 ADVERSE DRUG REACTION | 6 0.06 3.13 ADVERSE EVENT | 15 0.15 3.28 ADVERSE REACTION | 1 0.01 3.29 AGEUSIA | 4 0.04 3.33 AGGRESSION | 12 0.12 3.45 AGITATION | 20 0.20 3.65 AGRANULOCYTOSIS | 7 0.07 3.72 ALANINE AMINOTRANSFERASE INCREASED | 14 0.14 3.86 ALBUMIN URINE PRESENT | 1 0.01 3.87 ALCOHOL INTERACTION | 1 0.01 3.88 ALCOHOLISM | 1 0.01 3.89 ALLERGY TO CHEMICALS | 1 0.01 3.90 ALOPECIA | 20 0.20 4.10 ALTERED STATE OF CONSCIOUSNESS | 5 0.05 4.15 ALTERED VISUAL DEPTH PERCEPTION | 1 0.01 4.16 AMENORRHOEA | 10 0.10 4.26 AMERICAN TRYPANOSOMIASIS | 1 0.01 4.27 AMMONIA INCREASED | 2 0.02 4.29 AMNESIA | 16 0.16 4.45 AMOEBIC COLITIS | 1 0.01 4.46 AMYLOIDOSIS | 1 0.01 4.47 AMYOTROPHY | 1 0.01 4.48 ANAEMIA | 41 0.41 4.89 ANAEMIA POSTOPERATIVE | 2 0.02 4.91 ANAL ABSCESS | 1 0.01 4.92 ANAL ATRESIA | 1 0.01 4.93 ANAL FISSURE | 2 0.02 4.95 ANAL FISTULA | 2 0.02 4.97 ANAL HAEMORRHAGE | 2 0.02 4.99 ANAPHYLACTIC REACTION | 4 0.04 5.03 ANAPHYLACTIC SHOCK | 3 0.03 5.06 ANAPHYLACTOID REACTION | 2 0.02 5.08 ANEURYSMECTOMY | 1 0.01 5.09 ANGER | 11 0.11 5.20 ANGINA PECTORIS | 2 0.02 5.22 ANGINA UNSTABLE | 2 0.02 5.24 ANGIOEDEMA | 21 0.21 5.45 ANGIOPATHY | 1 0.01 5.46 ANGIOPLASTY | 4 0.04 5.50 ANGLE CLOSURE GLAUCOMA | 3 0.03 5.53 ANHEDONIA | 2 0.02 5.55 ANKLE FRACTURE | 6 0.06 5.61 ANKYLOSING SPONDYLITIS | 1 0.01 5.62 ANORECTAL DISCOMFORT | 2 0.02 5.64 ANORECTAL DISORDER | 1 0.01 5.65 ANOSMIA | 5 0.05 5.70 ANOXIC ENCEPHALOPATHY | 1 0.01 5.71 ANTI-INSULIN ANTIBODY POSITIVE | 2 0.02 5.73 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY .. | 1 0.01 5.74 ANTICOAGULATION DRUG LEVEL BELOW THER.. | 1 0.01 5.75 ANTICONVULSANT DRUG LEVEL ABOVE THERA.. | 2 0.02 5.77 ANTICONVULSANT DRUG LEVEL DECREASED | 1 0.01 5.78 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE | 1 0.01 5.79 ANTIPHOSPHOLIPID SYNDROME | 4 0.04 5.83 ANTIPSYCHOTIC DRUG LEVEL INCREASED | 3 0.03 5.86 ANTISOCIAL BEHAVIOUR | 1 0.01 5.87 ANURIA | 4 0.04 5.91 ANXIETY | 35 0.35 6.26 AORTIC ANEURYSM | 2 0.02 6.28 AORTIC ANEURYSM REPAIR | 1 0.01 6.29 APALLIC SYNDROME | 1 0.01 6.30 APGAR SCORE LOW | 1 0.01 6.31 APHASIA | 7 0.07 6.38 APHONIA | 1 0.01 6.39 APHTHOUS STOMATITIS | 3 0.03 6.42 APLASIA PURE RED CELL | 1 0.01 6.43 APLASTIC ANAEMIA | 1 0.01 6.44 APNOEA | 3 0.03 6.47 APPENDICITIS | 1 0.01 6.48 APPENDIX DISORDER | 1 0.01 6.49 APPETITE DISORDER | 1 0.01 6.50 APPLICATION SITE ATROPHY | 1 0.01 6.51 APPLICATION SITE BURN | 7 0.07 6.58 APPLICATION SITE ERYTHEMA | 5 0.05 6.63 APPLICATION SITE INFLAMMATION | 2 0.02 6.65 APPLICATION SITE IRRITATION | 2 0.02 6.67 APPLICATION SITE PAIN | 1 0.01 6.68 APPLICATION SITE PRURITUS | 4 0.04 6.72 APPLICATION SITE RASH | 2 0.02 6.74 APPLICATION SITE SCAB | 2 0.02 6.76 APPLICATION SITE ULCER | 1 0.01 6.77 AREFLEXIA | 1 0.01 6.78 ARRHYTHMIA | 12 0.12 6.90 ARTERIAL BYPASS OPERATION | 1 0.01 6.91 ARTERIAL HAEMORRHAGE | 1 0.01 6.92 ARTERIAL OCCLUSIVE DISEASE | 2 0.02 6.94 ARTERIAL STENOSIS | 1 0.01 6.95 ARTERIAL THROMBOSIS | 1 0.01 6.96 ARTERIOSCLEROSIS | 4 0.04 7.00 ARTERIOSCLEROSIS CORONARY ARTERY | 1 0.01 7.01 ARTERIOSPASM CORONARY | 1 0.01 7.02 ARTERIOVENOUS FISTULA THROMBOSIS | 1 0.01 7.03 ARTHRALGIA | 53 0.53 7.56 ARTHRITIS | 6 0.06 7.62 ARTHRITIS BACTERIAL | 1 0.01 7.63 ARTHRITIS SALMONELLA | 1 0.01 7.64 ARTHROPATHY | 6 0.06 7.70 ASCITES | 6 0.06 7.76 ASPARTATE AMINOTRANSFERASE INCREASED | 14 0.14 7.90 ASPERGER'S DISORDER | 2 0.02 7.92 ASPERGILLOMA | 2 0.02 7.94 ASPERGILLOSIS | 2 0.02 7.96 ASPHYXIA | 1 0.01 7.97 ASPIRATION | 6 0.06 8.03 ASTERIXIS | 1 0.01 8.04 ASTHENIA | 56 0.56 8.60 ASTHENOPIA | 1 0.01 8.61 ASTHMA | 16 0.16 8.77 ASTHMA EXERCISE INDUCED | 2 0.02 8.79 ASTHMATIC CRISIS | 1 0.01 8.80 ATAXIA | 4 0.04 8.84 ATRIAL FIBRILLATION | 25 0.25 9.09 ATRIAL FLUTTER | 4 0.04 9.13 ATRIAL PRESSURE INCREASED | 1 0.01 9.14 ATRIOVENTRICULAR BLOCK | 2 0.02 9.16 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 2 0.02 9.18 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 1 0.01 9.19 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 1 0.01 9.20 ATYPICAL MYCOBACTERIAL INFECTION | 1 0.01 9.21 AURICULAR SWELLING | 3 0.03 9.24 AUTISM | 1 0.01 9.25 AUTOIMMUNE DISORDER | 1 0.01 9.26 AUTOIMMUNE HEPATITIS | 3 0.03 9.29 AUTOIMMUNE THYROIDITIS | 1 0.01 9.30 AZOTAEMIA | 2 0.02 9.32 B-CELL LYMPHOMA | 1 0.01 9.33 BACK DISORDER | 5 0.05 9.38 BACK PAIN | 35 0.35 9.73 BACTERIAL INFECTION | 2 0.02 9.75 BALANCE DISORDER | 12 0.12 9.87 BARRETT'S OESOPHAGUS | 4 0.04 9.91 BASAL CELL CARCINOMA | 5 0.05 9.96 BASOPHIL PERCENTAGE DECREASED | 1 0.01 9.97 BEDRIDDEN | 3 0.03 10.00 BENIGN INTRACRANIAL HYPERTENSION | 3 0.03 10.03 BENIGN PROSTATIC HYPERPLASIA | 2 0.02 10.05 BICUSPID AORTIC VALVE | 1 0.01 10.06 BIFASCICULAR BLOCK | 1 0.01 10.07 BILE DUCT OBSTRUCTION | 1 0.01 10.08 BILE DUCT STONE | 1 0.01 10.09 BILIARY FISTULA | 1 0.01 10.10 BILIARY ISCHAEMIA | 1 0.01 10.11 BILIRUBIN CONJUGATED INCREASED | 1 0.01 10.12 BIOPSY BILE DUCT ABNORMAL | 1 0.01 10.13 BIOPSY LIVER ABNORMAL | 1 0.01 10.14 BIPOLAR DISORDER | 2 0.02 10.16 BLADDER AGENESIS | 1 0.01 10.17 BLADDER CANCER | 1 0.01 10.18 BLADDER CANCER RECURRENT | 1 0.01 10.19 BLADDER DISORDER | 3 0.03 10.22 BLADDER INJURY | 1 0.01 10.23 BLADDER NEOPLASM | 1 0.01 10.24 BLADDER PERFORATION | 1 0.01 10.25 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA | 1 0.01 10.26 BLEPHARITIS | 1 0.01 10.27 BLEPHAROSPASM | 2 0.02 10.29 BLINDNESS | 10 0.10 10.39 BLINDNESS TRANSIENT | 1 0.01 10.40 BLINDNESS UNILATERAL | 1 0.01 10.41 BLISTER | 13 0.13 10.54 BLOOD ALBUMIN DECREASED | 3 0.03 10.57 BLOOD ALKALINE PHOSPHATASE INCREASED | 7 0.07 10.64 BLOOD AMYLASE INCREASED | 5 0.05 10.69 BLOOD BETA-D-GLUCAN INCREASED | 3 0.03 10.72 BLOOD BILIRUBIN INCREASED | 5 0.05 10.77 BLOOD BILIRUBIN UNCONJUGATED INCREASED | 1 0.01 10.78 BLOOD BLISTER | 1 0.01 10.79 BLOOD CALCIUM DECREASED | 6 0.06 10.85 BLOOD CALCIUM INCREASED | 1 0.01 10.86 BLOOD CHLORIDE INCREASED | 1 0.01 10.87 BLOOD CHOLESTEROL | 1 0.01 10.88 BLOOD CHOLESTEROL ABNORMAL | 1 0.01 10.89 BLOOD CHOLESTEROL INCREASED | 10 0.10 10.99 BLOOD COPPER DECREASED | 1 0.01 11.00 BLOOD COUNT ABNORMAL | 3 0.03 11.03 BLOOD CREATINE PHOSPHOKINASE | 3 0.03 11.06 BLOOD CREATINE PHOSPHOKINASE ABNORMAL | 1 0.01 11.07 BLOOD CREATINE PHOSPHOKINASE INCREASED | 10 0.10 11.17 BLOOD CREATININE ABNORMAL | 1 0.01 11.18 BLOOD CREATININE DECREASED | 1 0.01 11.19 BLOOD CREATININE INCREASED | 17 0.17 11.36 BLOOD CULTURE POSITIVE | 2 0.02 11.38 BLOOD DISORDER | 1 0.01 11.39 BLOOD FOLLICLE STIMULATING HORMONE IN.. | 1 0.01 11.40 BLOOD GLUCOSE ABNORMAL | 3 0.03 11.43 BLOOD GLUCOSE DECREASED | 10 0.10 11.53 BLOOD GLUCOSE FLUCTUATION | 2 0.02 11.55 BLOOD GLUCOSE INCREASED | 26 0.26 11.81 BLOOD HUMAN CHORIONIC GONADOTROPIN | 1 0.01 11.82 BLOOD HUMAN CHORIONIC GONADOTROPIN PO.. | 1 0.01 11.83 BLOOD IRON DECREASED | 2 0.02 11.85 BLOOD IRON INCREASED | 1 0.01 11.86 BLOOD LACTATE DEHYDROGENASE INCREASED | 6 0.06 11.92 BLOOD LUTEINISING HORMONE INCREASED | 1 0.01 11.93 BLOOD MAGNESIUM DECREASED | 3 0.03 11.96 BLOOD METHAEMOGLOBIN PRESENT | 1 0.01 11.97 BLOOD PH DECREASED | 1 0.01 11.98 BLOOD POTASSIUM ABNORMAL | 1 0.01 11.99 BLOOD POTASSIUM DECREASED | 3 0.03 12.02 BLOOD POTASSIUM INCREASED | 3 0.03 12.05 BLOOD PRESSURE ABNORMAL | 1 0.01 12.06 BLOOD PRESSURE DECREASED | 21 0.21 12.27 BLOOD PRESSURE DIASTOLIC DECREASED | 2 0.02 12.29 BLOOD PRESSURE FLUCTUATION | 1 0.01 12.30 BLOOD PRESSURE INADEQUATELY CONTROLLED | 1 0.01 12.31 BLOOD PRESSURE INCREASED | 29 0.29 12.60 BLOOD PRESSURE SYSTOLIC INCREASED | 6 0.06 12.66 BLOOD PROLACTIN ABNORMAL | 1 0.01 12.67 BLOOD SODIUM DECREASED | 4 0.04 12.71 BLOOD TEST ABNORMAL | 4 0.04 12.75 BLOOD TESTOSTERONE DECREASED | 1 0.01 12.76 BLOOD THYROID STIMULATING HORMONE ABN.. | 1 0.01 12.77 BLOOD THYROID STIMULATING HORMONE INC.. | 3 0.03 12.80 BLOOD TRIGLYCERIDES INCREASED | 4 0.04 12.84 BLOOD UREA DECREASED | 1 0.01 12.85 BLOOD UREA INCREASED | 8 0.08 12.93 BLOOD URIC ACID INCREASED | 1 0.01 12.94 BLOOD URINE PRESENT | 1 0.01 12.95 BODY HEIGHT DECREASED | 1 0.01 12.96 BODY TEMPERATURE INCREASED | 4 0.04 13.00 BONE CYST | 1 0.01 13.01 BONE DEBRIDEMENT | 2 0.02 13.03 BONE DENSITY ABNORMAL | 1 0.01 13.04 BONE DENSITY DECREASED | 5 0.05 13.09 BONE DISORDER | 15 0.15 13.24 BONE GRAFT | 1 0.01 13.25 BONE LESION | 1 0.01 13.26 BONE MARROW DISORDER | 2 0.02 13.28 BONE MARROW FAILURE | 3 0.03 13.31 BONE MARROW TRANSPLANT | 4 0.04 13.35 BONE OPERATION | 5 0.05 13.40 BONE PAIN | 6 0.06 13.46 BONE SWELLING | 4 0.04 13.50 BOVINE TUBERCULOSIS | 1 0.01 13.51 BOWEN'S DISEASE | 1 0.01 13.52 BRADYCARDIA | 20 0.20 13.72 BRADYPHRENIA | 1 0.01 13.73 BRAIN CONTUSION | 1 0.01 13.74 BRAIN DEATH | 1 0.01 13.75 BRAIN NEOPLASM | 3 0.03 13.78 BRAIN OEDEMA | 2 0.02 13.80 BRAIN OPERATION | 1 0.01 13.81 BREAKTHROUGH PAIN | 2 0.02 13.83 BREAST CANCER | 13 0.13 13.96 BREAST CANCER FEMALE | 1 0.01 13.97 BREAST CANCER IN SITU | 1 0.01 13.98 BREAST CANCER METASTATIC | 5 0.05 14.03 BREAST CANCER RECURRENT | 3 0.03 14.06 BREAST ENLARGEMENT | 1 0.01 14.07 BREAST INFECTION | 1 0.01 14.08 BREAST LUMP REMOVAL | 1 0.01 14.09 BREAST PAIN | 4 0.04 14.13 BREAST SWELLING | 2 0.02 14.15 BREAST TENDERNESS | 3 0.03 14.18 BREATH ODOUR | 2 0.02 14.20 BREATH SOUNDS ABNORMAL | 1 0.01 14.21 BRONCHIAL FISTULA | 1 0.01 14.22 BRONCHIAL HAEMORRHAGE | 1 0.01 14.23 BRONCHIAL SECRETION RETENTION | 1 0.01 14.24 BRONCHIECTASIS | 1 0.01 14.25 BRONCHIOLITIS | 2 0.02 14.27 BRONCHITIS | 13 0.13 14.40 BRONCHOPNEUMONIA | 1 0.01 14.41 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 14.42 BRONCHOSPASM | 8 0.08 14.50 BRUGADA SYNDROME | 1 0.01 14.51 BRUXISM | 3 0.03 14.54 BUNDLE BRANCH BLOCK LEFT | 1 0.01 14.55 BUNDLE BRANCH BLOCK RIGHT | 1 0.01 14.56 BURKITT'S LYMPHOMA | 1 0.01 14.57 BURNING MOUTH SYNDROME | 1 0.01 14.58 BURNING SENSATION | 12 0.12 14.70 BURNS SECOND DEGREE | 1 0.01 14.71 BURSITIS | 1 0.01 14.72 C-REACTIVE PROTEIN | 1 0.01 14.73 C-REACTIVE PROTEIN INCREASED | 8 0.08 14.81 CACHEXIA | 1 0.01 14.82 CAESAREAN SECTION | 1 0.01 14.83 CALCULUS URETERIC | 2 0.02 14.85 CANCER PAIN | 2 0.02 14.87 CANDIDIASIS | 4 0.04 14.91 CARBOHYDRATE ANTIGEN 125 INCREASED | 2 0.02 14.93 CARBON DIOXIDE INCREASED | 2 0.02 14.95 CARCINOEMBRYONIC ANTIGEN INCREASED | 2 0.02 14.97 CARCINOID TUMOUR OF THE STOMACH | 1 0.01 14.98 CARDIAC ARREST | 24 0.24 15.22 CARDIAC DISCOMFORT | 1 0.01 15.23 CARDIAC DISORDER | 25 0.25 15.48 CARDIAC ENZYMES INCREASED | 1 0.01 15.49 CARDIAC FAILURE | 17 0.17 15.66 CARDIAC FAILURE CONGESTIVE | 14 0.14 15.80 CARDIAC FLUTTER | 1 0.01 15.81 CARDIAC FUNCTION TEST ABNORMAL | 1 0.01 15.82 CARDIAC MURMUR | 1 0.01 15.83 CARDIAC OPERATION | 2 0.02 15.85 CARDIAC PACEMAKER INSERTION | 2 0.02 15.87 CARDIAC TAMPONADE | 1 0.01 15.88 CARDIO-RESPIRATORY ARREST | 10 0.10 15.98 CARDIOGENIC SHOCK | 1 0.01 15.99 CARDIOMEGALY | 3 0.03 16.02 CARDIOMYOPATHY | 1 0.01 16.03 CARDIOPULMONARY FAILURE | 1 0.01 16.04 CARDIOTOXICITY | 3 0.03 16.07 CARDIOVASCULAR DISORDER | 7 0.07 16.14 CAROTID ARTERY OCCLUSION | 2 0.02 16.16 CARPAL TUNNEL SYNDROME | 3 0.03 16.19 CARTILAGE INJURY | 1 0.01 16.20 CATARACT | 14 0.14 16.34 CATARACT OPERATION | 2 0.02 16.36 CATATONIA | 1 0.01 16.37 CATHETERISATION CARDIAC | 4 0.04 16.41 CAUDAL REGRESSION SYNDROME | 2 0.02 16.43 CAUSTIC INJURY | 1 0.01 16.44 CD4 LYMPHOCYTES DECREASED | 2 0.02 16.46 CELL DEATH | 1 0.01 16.47 CELL MARKER INCREASED | 1 0.01 16.48 CELLULITIS | 13 0.13 16.61 CENTRAL NERVOUS SYSTEM LESION | 4 0.04 16.65 CEREBELLAR SYNDROME | 1 0.01 16.66 CEREBRAL ARTERY EMBOLISM | 2 0.02 16.68 CEREBRAL ASPERGILLOSIS | 1 0.01 16.69 CEREBRAL HAEMATOMA | 2 0.02 16.71 CEREBRAL HAEMORRHAGE | 5 0.05 16.76 CEREBRAL INFARCTION | 4 0.04 16.80 CEREBRAL ISCHAEMIA | 1 0.01 16.81 CEREBRAL THROMBOSIS | 2 0.02 16.83 CEREBRAL TOXOPLASMOSIS | 1 0.01 16.84 CEREBRAL VENOUS THROMBOSIS | 1 0.01 16.85 CEREBROVASCULAR ACCIDENT | 34 0.34 17.19 CERVICAL DYSPLASIA | 2 0.02 17.21 CHAPPED LIPS | 2 0.02 17.23 CHEILITIS | 2 0.02 17.25 CHEMICAL BURNS OF EYE | 1 0.01 17.26 CHEST DISCOMFORT | 20 0.20 17.46 CHEST PAIN | 37 0.37 17.83 CHEST X-RAY ABNORMAL | 1 0.01 17.84 CHILLS | 16 0.16 18.00 CHLOASMA | 1 0.01 18.01 CHLOROMA | 1 0.01 18.02 CHOKING | 1 0.01 18.03 CHOLANGITIS | 4 0.04 18.07 CHOLECYSTECTOMY | 36 0.36 18.43 CHOLECYSTITIS | 9 0.09 18.52 CHOLECYSTITIS ACUTE | 1 0.01 18.53 CHOLECYSTITIS CHRONIC | 1 0.01 18.54 CHOLECYSTITIS INFECTIVE | 1 0.01 18.55 CHOLELITHIASIS | 8 0.08 18.63 CHOLESTASIS | 6 0.06 18.69 CHOLESTATIC LIVER INJURY | 2 0.02 18.71 CHOLINERGIC SYNDROME | 1 0.01 18.72 CHONDROPATHY | 1 0.01 18.73 CHROMATOPSIA | 1 0.01 18.74 CHROMATURIA | 5 0.05 18.79 CHRONIC ALLOGRAFT NEPHROPATHY | 1 0.01 18.80 CHRONIC FATIGUE SYNDROME | 1 0.01 18.81 CHRONIC GRAFT VERSUS HOST DISEASE | 1 0.01 18.82 CHRONIC LYMPHOCYTIC LEUKAEMIA | 1 0.01 18.83 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 10 0.10 18.93 CIRCULATORY COLLAPSE | 11 0.11 19.04 CLAVICLE FRACTURE | 1 0.01 19.05 CLOACAL EXSTROPHY | 2 0.02 19.07 CLOSTRIDIAL INFECTION | 5 0.05 19.12 CLOSTRIDIUM DIFFICILE COLITIS | 3 0.03 19.15 COAGULATION TEST ABNORMAL | 1 0.01 19.16 COAGULOPATHY | 5 0.05 19.21 COGNITIVE DISORDER | 3 0.03 19.24 COLD SWEAT | 3 0.03 19.27 COLECTOMY | 3 0.03 19.30 COLITIS | 4 0.04 19.34 COLITIS COLLAGENOUS | 1 0.01 19.35 COLITIS ISCHAEMIC | 2 0.02 19.37 COLITIS ULCERATIVE | 3 0.03 19.40 COLON CANCER | 4 0.04 19.44 COLON CANCER METASTATIC | 1 0.01 19.45 COLON OPERATION | 1 0.01 19.46 COLON POLYPECTOMY | 1 0.01 19.47 COLONIC POLYP | 1 0.01 19.48 COLOSTOMY | 2 0.02 19.50 COMA | 7 0.07 19.57 COMA SCALE ABNORMAL | 7 0.07 19.64 COMMUNICATION DISORDER | 2 0.02 19.66 COMPLETED SUICIDE | 5 0.05 19.71 COMPLEX PARTIAL SEIZURES | 1 0.01 19.72 COMPLICATION OF DEVICE INSERTION | 2 0.02 19.74 COMPLICATIONS OF TRANSPLANT SURGERY | 1 0.01 19.75 COMPRESSION FRACTURE | 1 0.01 19.76 CONCOMITANT DISEASE PROGRESSION | 1 0.01 19.77 CONDITION AGGRAVATED | 37 0.37 20.14 CONDUCTION DISORDER | 2 0.02 20.16 CONDUCTIVE DEAFNESS | 1 0.01 20.17 CONFUSIONAL STATE | 34 0.34 20.51 CONGENITAL ANOMALY | 2 0.02 20.53 CONGENITAL GENITAL MALFORMATION | 1 0.01 20.54 CONGENITAL TRACHEOMALACIA | 1 0.01 20.55 CONJUNCTIVAL HYPERAEMIA | 1 0.01 20.56 CONJUNCTIVITIS | 3 0.03 20.59 CONSCIOUSNESS FLUCTUATING | 1 0.01 20.60 CONSTIPATION | 29 0.29 20.89 CONTACT LENS INTOLERANCE | 1 0.01 20.90 CONTRALATERAL BREAST CANCER | 1 0.01 20.91 CONTRAST MEDIA REACTION | 3 0.03 20.94 CONTUSION | 12 0.12 21.06 CONVERSION DISORDER | 1 0.01 21.07 CONVULSION | 50 0.50 21.57 CONVULSION NEONATAL | 1 0.01 21.58 COOMBS POSITIVE HAEMOLYTIC ANAEMIA | 2 0.02 21.60 COORDINATION ABNORMAL | 3 0.03 21.63 CORNEAL ABRASION | 1 0.01 21.64 CORNEAL DEPOSITS | 1 0.01 21.65 CORNEAL OPACITY | 1 0.01 21.66 CORONARY ANGIOPLASTY | 1 0.01 21.67 CORONARY ARTERIAL STENT INSERTION | 1 0.01 21.68 CORONARY ARTERY ANEURYSM | 1 0.01 21.69 CORONARY ARTERY BYPASS | 6 0.06 21.75 CORONARY ARTERY DISEASE | 11 0.11 21.86 CORONARY ARTERY OCCLUSION | 2 0.02 21.88 CORONARY ARTERY RESTENOSIS | 1 0.01 21.89 COUGH | 30 0.30 22.19 COXSACKIE VIRAL INFECTION | 1 0.01 22.20 CRANIAL NERVE DISORDER | 1 0.01 22.21 CRANIOTOMY | 1 0.01 22.22 CREATININE RENAL CLEARANCE DECREASED | 1 0.01 22.23 CREATININE RENAL CLEARANCE INCREASED | 1 0.01 22.24 CROHN'S DISEASE | 7 0.07 22.31 CRYING | 8 0.08 22.39 CRYPTOCOCCOSIS | 1 0.01 22.40 CRYPTORCHISM | 1 0.01 22.41 CRYPTOSPORIDIOSIS INFECTION | 1 0.01 22.42 CRYSTALLURIA | 1 0.01 22.43 CULTURE POSITIVE | 1 0.01 22.44 CULTURE WOUND POSITIVE | 1 0.01 22.45 CUTANEOUS VASCULITIS | 3 0.03 22.48 CYANOSIS | 8 0.08 22.56 CYANOSIS NEONATAL | 2 0.02 22.58 CYCLIC VOMITING SYNDROME | 1 0.01 22.59 CYST | 2 0.02 22.61 CYSTITIS | 3 0.03 22.64 CYSTOPEXY | 1 0.01 22.65 CYTOLYTIC HEPATITIS | 7 0.07 22.72 CYTOMEGALOVIRUS INFECTION | 5 0.05 22.77 DEAFNESS | 4 0.04 22.81 DEAFNESS BILATERAL | 1 0.01 22.82 DEAFNESS NEUROSENSORY | 1 0.01 22.83 DEATH | 136 1.36 24.19 DEBRIDEMENT | 1 0.01 24.20 DECREASED ACTIVITY | 1 0.01 24.21 DECREASED APPETITE | 29 0.29 24.50 DECREASED VIBRATORY SENSE | 1 0.01 24.51 DECUBITUS ULCER | 5 0.05 24.56 DEEP VEIN THROMBOSIS | 24 0.24 24.80 DEFORMITY | 2 0.02 24.82 DEHYDRATION | 28 0.28 25.10 DELAYED RECOVERY FROM ANAESTHESIA | 3 0.03 25.13 DELIRIUM | 11 0.11 25.24 DELUSION | 5 0.05 25.29 DEMENTIA | 2 0.02 25.31 DEMENTIA ALZHEIMER'S TYPE | 1 0.01 25.32 DEMYELINATING POLYNEUROPATHY | 1 0.01 25.33 DEMYELINATION | 3 0.03 25.36 DENTAL CARIES | 7 0.07 25.43 DENTAL IMPLANTATION | 1 0.01 25.44 DENTAL OPERATION | 1 0.01 25.45 DENTAL PLAQUE | 1 0.01 25.46 DEPERSONALISATION | 1 0.01 25.47 DEPRESSED LEVEL OF CONSCIOUSNESS | 13 0.13 25.60 DEPRESSED MOOD | 14 0.14 25.74 DEPRESSION | 42 0.42 26.16 DEPRESSION SUICIDAL | 2 0.02 26.18 DERMAL CYST | 1 0.01 26.19 DERMATITIS ACNEIFORM | 3 0.03 26.22 DERMATITIS ALLERGIC | 2 0.02 26.24 DERMATITIS CONTACT | 1 0.01 26.25 DERMATITIS EXFOLIATIVE GENERALISED | 1 0.01 26.26 DEVELOPMENTAL DELAY | 1 0.01 26.27 DEVICE BREAKAGE | 2 0.02 26.29 DEVICE DISLOCATION | 10 0.10 26.39 DEVICE EXPULSION | 41 0.41 26.80 DEVICE FAILURE | 1 0.01 26.81 DEVICE MALFUNCTION | 14 0.14 26.95 DEVICE OCCLUSION | 1 0.01 26.96 DEVICE RELATED INFECTION | 3 0.03 26.99 DIABETES MELLITUS | 19 0.19 27.18 DIABETES MELLITUS INADEQUATE CONTROL | 2 0.02 27.20 DIABETIC COMA | 1 0.01 27.21 DIABETIC COMPLICATION | 1 0.01 27.22 DIABETIC HYPERGLYCAEMIC COMA | 1 0.01 27.23 DIABETIC KETOACIDOSIS | 1 0.01 27.24 DIABETIC NEUROPATHY | 1 0.01 27.25 DIABETIC RETINOPATHY | 1 0.01 27.26 DIALYSIS | 4 0.04 27.30 DIAPHRAGMALGIA | 1 0.01 27.31 DIARRHOEA | 101 1.01 28.32 DIARRHOEA HAEMORRHAGIC | 3 0.03 28.35 DILATATION ATRIAL | 1 0.01 28.36 DIPLOPIA | 3 0.03 28.39 DISABILITY | 3 0.03 28.42 DISCOMFORT | 2 0.02 28.44 DISEASE PROGRESSION | 13 0.13 28.57 DISEASE RECURRENCE | 3 0.03 28.60 DISORIENTATION | 9 0.09 28.69 DISSEMINATED INTRAVASCULAR COAGULATION | 7 0.07 28.76 DISSEMINATED TUBERCULOSIS | 1 0.01 28.77 DISTURBANCE IN ATTENTION | 8 0.08 28.85 DIVERTICULAR PERFORATION | 1 0.01 28.86 DIVERTICULITIS | 7 0.07 28.93 DIVERTICULUM | 4 0.04 28.97 DIVERTICULUM INTESTINAL | 1 0.01 28.98 DIZZINESS | 87 0.87 29.85 DIZZINESS POSTURAL | 2 0.02 29.87 DNA ANTIBODY POSITIVE | 1 0.01 29.88 DROOLING | 1 0.01 29.89 DRUG ABUSE | 6 0.06 29.95 DRUG ABUSER | 1 0.01 29.96 DRUG ADMINISTERED AT INAPPROPRIATE SITE | 3 0.03 29.99 DRUG ADMINISTRATION ERROR | 12 0.12 30.11 DRUG DEPENDENCE | 9 0.09 30.20 DRUG DISPENSING ERROR | 3 0.03 30.23 DRUG DOSE OMISSION | 11 0.11 30.34 DRUG EFFECT DECREASED | 7 0.07 30.41 DRUG EFFECT INCREASED | 1 0.01 30.42 DRUG ERUPTION | 3 0.03 30.45 DRUG EXPOSURE BEFORE PREGNANCY | 1 0.01 30.46 DRUG EXPOSURE DURING PREGNANCY | 30 0.30 30.76 DRUG HYPERSENSITIVITY | 15 0.15 30.91 DRUG INEFFECTIVE | 93 0.93 31.84 DRUG INTERACTION | 44 0.44 32.28 DRUG INTOLERANCE | 4 0.04 32.32 DRUG LEVEL ABOVE THERAPEUTIC | 1 0.01 32.33 DRUG LEVEL INCREASED | 1 0.01 32.34 DRUG PRESCRIBING ERROR | 7 0.07 32.41 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 6 0.06 32.47 DRUG RESISTANCE | 12 0.12 32.59 DRUG SCREEN FALSE POSITIVE | 2 0.02 32.61 DRUG SCREEN POSITIVE | 1 0.01 32.62 DRUG TOXICITY | 16 0.16 32.78 DRUG WITHDRAWAL HEADACHE | 1 0.01 32.79 DRUG WITHDRAWAL SYNDROME | 10 0.10 32.89 DRY EYE | 7 0.07 32.96 DRY MOUTH | 15 0.15 33.11 DRY SKIN | 10 0.10 33.21 DRY THROAT | 2 0.02 33.23 DUODENAL ULCER | 3 0.03 33.26 DUODENAL ULCER PERFORATION | 1 0.01 33.27 DUODENITIS | 2 0.02 33.29 DURAL FISTULA | 1 0.01 33.30 DYSARTHRIA | 17 0.17 33.47 DYSGEUSIA | 16 0.16 33.63 DYSGRAPHIA | 1 0.01 33.64 DYSKINESIA | 9 0.09 33.73 DYSKINESIA NEONATAL | 2 0.02 33.75 DYSLALIA | 1 0.01 33.76 DYSMENORRHOEA | 2 0.02 33.78 DYSPAREUNIA | 2 0.02 33.80 DYSPEPSIA | 12 0.12 33.92 DYSPHAGIA | 16 0.16 34.08 DYSPHONIA | 15 0.15 34.23 DYSPNOEA | 111 1.11 35.34 DYSPNOEA AT REST | 1 0.01 35.35 DYSPNOEA EXERTIONAL | 8 0.08 35.43 DYSSTASIA | 7 0.07 35.50 DYSTONIA | 1 0.01 35.51 DYSURIA | 7 0.07 35.58 EAR DISCOMFORT | 1 0.01 35.59 EAR INFECTION | 3 0.03 35.62 EAR PAIN | 5 0.05 35.67 EATING DISORDER | 5 0.05 35.72 ECONOMIC PROBLEM | 1 0.01 35.73 ECTOPIC PREGNANCY | 1 0.01 35.74 ECTOPIC PREGNANCY WITH INTRAUTERINE D.. | 2 0.02 35.76 ECZEMA | 6 0.06 35.82 EDENTULOUS | 1 0.01 35.83 EFFUSION | 1 0.01 35.84 EJACULATION DISORDER | 1 0.01 35.85 EJECTION FRACTION DECREASED | 2 0.02 35.87 ELECTROCARDIOGRAM ABNORMAL | 1 0.01 35.88 ELECTROCARDIOGRAM QT PROLONGED | 10 0.10 35.98 ELECTROCARDIOGRAM RR INTERVAL PROLONGED | 1 0.01 35.99 ELECTROCARDIOGRAM T WAVE INVERSION | 1 0.01 36.00 ELECTROENCEPHALOGRAM ABNORMAL | 1 0.01 36.01 ELECTROLYTE IMBALANCE | 4 0.04 36.05 EMOTIONAL DISORDER | 6 0.06 36.11 EMOTIONAL DISTRESS | 8 0.08 36.19 EMPHYSEMA | 2 0.02 36.21 ENAMEL ANOMALY | 1 0.01 36.22 ENCEPHALITIS | 3 0.03 36.25 ENCEPHALOPATHY | 4 0.04 36.29 ENDOCARDITIS | 2 0.02 36.31 ENDOCRINE DISORDER | 1 0.01 36.32 ENERGY INCREASED | 1 0.01 36.33 ENTEROBACTER INFECTION | 1 0.01 36.34 ENTEROCOCCAL INFECTION | 1 0.01 36.35 ENTEROCOCCAL SEPSIS | 1 0.01 36.36 ENTEROCOLITIS | 2 0.02 36.38 ENTEROCOLITIS INFECTIOUS | 1 0.01 36.39 EOSINOPHIL COUNT ABNORMAL | 1 0.01 36.40 EOSINOPHIL COUNT DECREASED | 1 0.01 36.41 EOSINOPHIL PERCENTAGE INCREASED | 1 0.01 36.42 EOSINOPHILIA | 2 0.02 36.44 EOSINOPHILIC MYOCARDITIS | 1 0.01 36.45 EOSINOPHILIC PNEUMONIA | 2 0.02 36.47 EOSINOPHILIC PNEUMONIA ACUTE | 1 0.01 36.48 EPIGLOTTIC OEDEMA | 1 0.01 36.49 EPILEPSY | 5 0.05 36.54 EPISTAXIS | 20 0.20 36.74 EPSTEIN-BARR VIRUS INFECTION | 1 0.01 36.75 ERECTILE DYSFUNCTION | 5 0.05 36.80 ERECTION INCREASED | 2 0.02 36.82 EROSIVE DUODENITIS | 1 0.01 36.83 ERUCTATION | 1 0.01 36.84 ERYTHEMA | 28 0.28 37.12 ERYTHEMA MULTIFORME | 3 0.03 37.15 ERYTHEMA NODOSUM | 1 0.01 37.16 ESCHERICHIA BACTERAEMIA | 1 0.01 37.17 ESCHERICHIA INFECTION | 2 0.02 37.19 ESCHERICHIA SEPSIS | 2 0.02 37.21 EUPHORIC MOOD | 3 0.03 37.24 EXCESSIVE EYE BLINKING | 1 0.01 37.25 EXCESSIVE GRANULATION TISSUE | 1 0.01 37.26 EXERCISE LACK OF | 1 0.01 37.27 EXERCISE TOLERANCE DECREASED | 3 0.03 37.30 EXOMPHALOS | 1 0.01 37.31 EXOSTOSIS | 3 0.03 37.34 EXPIRED DRUG ADMINISTERED | 3 0.03 37.37 EXTENSOR PLANTAR RESPONSE | 1 0.01 37.38 EXTRADURAL HAEMATOMA | 2 0.02 37.40 EXTRANODAL MARGINAL ZONE B-CELL LYMPH.. | 1 0.01 37.41 EXTRAOCULAR MUSCLE PARESIS | 1 0.01 37.42 EXTRAPYRAMIDAL DISORDER | 2 0.02 37.44 EXTREMITY CONTRACTURE | 2 0.02 37.46 EXTREMITY NECROSIS | 1 0.01 37.47 EYE DISORDER | 5 0.05 37.52 EYE HAEMORRHAGE | 1 0.01 37.53 EYE INFECTION | 1 0.01 37.54 EYE INJURY | 2 0.02 37.56 EYE IRRITATION | 7 0.07 37.63 EYE MOVEMENT DISORDER | 1 0.01 37.64 EYE PAIN | 11 0.11 37.75 EYE PRURITUS | 3 0.03 37.78 EYE ROLLING | 1 0.01 37.79 EYE SWELLING | 6 0.06 37.85 EYELID OEDEMA | 1 0.01 37.86 EYELID PTOSIS | 2 0.02 37.88 FACE INJURY | 1 0.01 37.89 FACE OEDEMA | 6 0.06 37.95 FACIAL PAIN | 3 0.03 37.98 FACIAL PALSY | 5 0.05 38.03 FACTOR VIII INHIBITION | 1 0.01 38.04 FAECAL INCONTINENCE | 1 0.01 38.05 FAECALITH | 1 0.01 38.06 FAECALOMA | 1 0.01 38.07 FAECES DISCOLOURED | 9 0.09 38.16 FALL | 68 0.68 38.84 FALLOPIAN TUBE CYST | 1 0.01 38.85 FALLOPIAN TUBE DISORDER | 1 0.01 38.86 FALSE NEGATIVE PREGNANCY TEST | 1 0.01 38.87 FAT TISSUE INCREASED | 1 0.01 38.88 FATIGUE | 73 0.73 39.61 FEAR | 6 0.06 39.67 FEBRILE CONVULSION | 1 0.01 39.68 FEBRILE NEUTROPENIA | 16 0.16 39.84 FEEDING DISORDER | 1 0.01 39.85 FEEDING DISORDER NEONATAL | 1 0.01 39.86 FEELING ABNORMAL | 33 0.33 40.19 FEELING COLD | 7 0.07 40.26 FEELING DRUNK | 2 0.02 40.28 FEELING HOT | 6 0.06 40.34 FEELING JITTERY | 1 0.01 40.35 FEELING OF BODY TEMPERATURE CHANGE | 1 0.01 40.36 FEELING OF DESPAIR | 1 0.01 40.37 FEMALE GENITAL TRACT FISTULA | 1 0.01 40.38 FEMORAL ARTERY OCCLUSION | 1 0.01 40.39 FEMORAL NECK FRACTURE | 2 0.02 40.41 FEMUR FRACTURE | 10 0.10 40.51 FIBROMYALGIA | 3 0.03 40.54 FIBROSIS | 5 0.05 40.59 FIBULA FRACTURE | 1 0.01 40.60 FINGER AMPUTATION | 1 0.01 40.61 FISTULA | 4 0.04 40.65 FISTULA DISCHARGE | 1 0.01 40.66 FLANK PAIN | 1 0.01 40.67 FLATULENCE | 12 0.12 40.79 FLUID OVERLOAD | 1 0.01 40.80 FLUID RETENTION | 8 0.08 40.88 FLUSHING | 7 0.07 40.95 FOCAL SEGMENTAL GLOMERULOSCLEROSIS | 1 0.01 40.96 FOETAL DISORDER | 1 0.01 40.97 FOETAL GROWTH RETARDATION | 1 0.01 40.98 FOOD CRAVING | 1 0.01 40.99 FOOD INTERACTION | 1 0.01 41.00 FOOD POISONING | 2 0.02 41.02 FOOT AMPUTATION | 1 0.01 41.03 FOOT FRACTURE | 2 0.02 41.05 FOOT OPERATION | 3 0.03 41.08 FOREIGN BODY SENSATION IN EYES | 2 0.02 41.10 FORMICATION | 1 0.01 41.11 FRACTURE | 2 0.02 41.13 FREQUENT BOWEL MOVEMENTS | 2 0.02 41.15 FUCHS' SYNDROME | 1 0.01 41.16 FUNCTIONAL RESIDUAL CAPACITY DECREASED | 1 0.01 41.17 FUNGAL INFECTION | 4 0.04 41.21 FUNGAL OESOPHAGITIS | 2 0.02 41.23 GAIT DISTURBANCE | 29 0.29 41.52 GALACTORRHOEA | 1 0.01 41.53 GALLBLADDER CANCER | 1 0.01 41.54 GALLBLADDER CANCER STAGE IV | 1 0.01 41.55 GALLBLADDER DISORDER | 20 0.20 41.75 GALLBLADDER INJURY | 1 0.01 41.76 GALLBLADDER NON-FUNCTIONING | 1 0.01 41.77 GALLBLADDER OPERATION | 4 0.04 41.81 GALLBLADDER PERFORATION | 1 0.01 41.82 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 10 0.10 41.92 GANGRENE | 2 0.02 41.94 GASTRIC BYPASS | 1 0.01 41.95 GASTRIC CANCER | 4 0.04 41.99 GASTRIC DISORDER | 10 0.10 42.09 GASTRIC HAEMORRHAGE | 4 0.04 42.13 GASTRIC ULCER | 8 0.08 42.21 GASTRIC ULCER HAEMORRHAGE | 1 0.01 42.22 GASTRITIS | 10 0.10 42.32 GASTRITIS EROSIVE | 1 0.01 42.33 GASTROENTERITIS | 4 0.04 42.37 GASTROENTERITIS VIRAL | 1 0.01 42.38 GASTROINTESTINAL CARCINOMA | 1 0.01 42.39 GASTROINTESTINAL DISORDER | 13 0.13 42.52 GASTROINTESTINAL EROSION | 1 0.01 42.53 GASTROINTESTINAL HAEMORRHAGE | 16 0.16 42.69 GASTROINTESTINAL HYPOMOTILITY | 4 0.04 42.73 GASTROINTESTINAL ISCHAEMIA | 1 0.01 42.74 GASTROINTESTINAL MOTILITY DISORDER | 2 0.02 42.76 GASTROINTESTINAL NECROSIS | 1 0.01 42.77 GASTROINTESTINAL PAIN | 2 0.02 42.79 GASTROINTESTINAL SOUNDS ABNORMAL | 1 0.01 42.80 GASTROINTESTINAL TUBE INSERTION | 2 0.02 42.82 GASTROOESOPHAGEAL REFLUX DISEASE | 13 0.13 42.95 GAZE PALSY | 1 0.01 42.96 GENERAL PHYSICAL CONDITION ABNORMAL | 1 0.01 42.97 GENERAL PHYSICAL HEALTH DETERIORATION | 22 0.22 43.19 GENERALISED ERYTHEMA | 4 0.04 43.23 GENERALISED OEDEMA | 3 0.03 43.26 GENITAL HAEMORRHAGE | 3 0.03 43.29 GENITAL PAIN | 1 0.01 43.30 GENITAL RASH | 1 0.01 43.31 GINGIVAL ABSCESS | 1 0.01 43.32 GINGIVAL BLEEDING | 5 0.05 43.37 GINGIVAL DISCOLOURATION | 1 0.01 43.38 GINGIVAL DISORDER | 4 0.04 43.42 GINGIVAL HYPERPLASIA | 1 0.01 43.43 GINGIVAL OEDEMA | 1 0.01 43.44 GINGIVAL PAIN | 1 0.01 43.45 GINGIVAL RECESSION | 1 0.01 43.46 GINGIVAL SWELLING | 3 0.03 43.49 GINGIVITIS | 1 0.01 43.50 GLAUCOMA | 4 0.04 43.54 GLIOBLASTOMA | 1 0.01 43.55 GLOMERULAR FILTRATION RATE DECREASED | 3 0.03 43.58 GLOMERULONEPHRITIS | 1 0.01 43.59 GLOSSODYNIA | 1 0.01 43.60 GLUCAGON SECRETION DISORDER | 1 0.01 43.61 GLUCOSE TOLERANCE IMPAIRED | 3 0.03 43.64 GLYCOSURIA | 1 0.01 43.65 GLYCOSYLATED HAEMOGLOBIN INCREASED | 1 0.01 43.66 GOITRE | 1 0.01 43.67 GOUT | 1 0.01 43.68 GRAFT COMPLICATION | 1 0.01 43.69 GRAFT DYSFUNCTION | 1 0.01 43.70 GRAFT INFECTION | 1 0.01 43.71 GRAND MAL CONVULSION | 13 0.13 43.84 GRANULOMA ANNULARE | 1 0.01 43.85 GRIMACING | 1 0.01 43.86 GROIN INFECTION | 1 0.01 43.87 GROIN PAIN | 3 0.03 43.90 GROWTH RETARDATION | 1 0.01 43.91 GUILLAIN-BARRE SYNDROME | 3 0.03 43.94 GUN SHOT WOUND | 1 0.01 43.95 H1N1 INFLUENZA | 2 0.02 43.97 HAEMANGIOMA | 3 0.03 44.00 HAEMATEMESIS | 9 0.09 44.09 HAEMATOCHEZIA | 9 0.09 44.18 HAEMATOCRIT ABNORMAL | 1 0.01 44.19 HAEMATOCRIT DECREASED | 6 0.06 44.25 HAEMATOLOGICAL MALIGNANCY | 2 0.02 44.27 HAEMATOMA | 2 0.02 44.29 HAEMATOTOXICITY | 5 0.05 44.34 HAEMATURIA | 12 0.12 44.46 HAEMODIALYSIS | 2 0.02 44.48 HAEMODYNAMIC INSTABILITY | 1 0.01 44.49 HAEMOGLOBIN ABNORMAL | 1 0.01 44.50 HAEMOGLOBIN DECREASED | 34 0.34 44.84 HAEMOGLOBINURIA | 1 0.01 44.85 HAEMOLYSIS | 2 0.02 44.87 HAEMOLYTIC ANAEMIA | 5 0.05 44.92 HAEMOPHILUS INFECTION | 1 0.01 44.93 HAEMOPTYSIS | 5 0.05 44.98 HAEMORRHAGE | 17 0.17 45.15 HAEMORRHAGE INTRACRANIAL | 2 0.02 45.17 HAEMORRHAGE SUBCUTANEOUS | 1 0.01 45.18 HAEMORRHAGE URINARY TRACT | 1 0.01 45.19 HAEMORRHAGIC CEREBRAL INFARCTION | 1 0.01 45.20 HAEMORRHAGIC DIATHESIS | 5 0.05 45.25 HAEMORRHAGIC OVARIAN CYST | 2 0.02 45.27 HAEMORRHAGIC STROKE | 2 0.02 45.29 HAEMORRHOIDAL HAEMORRHAGE | 1 0.01 45.30 HAEMORRHOIDS | 6 0.06 45.36 HAEMOSIDEROSIS | 1 0.01 45.37 HAIR COLOUR CHANGES | 1 0.01 45.38 HAIR DISORDER | 1 0.01 45.39 HAIR GROWTH ABNORMAL | 1 0.01 45.40 HAIR TEXTURE ABNORMAL | 1 0.01 45.41 HALLUCINATION | 18 0.18 45.59 HALLUCINATION, AUDITORY | 1 0.01 45.60 HALLUCINATION, VISUAL | 5 0.05 45.65 HALLUCINATIONS, MIXED | 1 0.01 45.66 HAND FRACTURE | 1 0.01 45.67 HAPTOGLOBIN DECREASED | 1 0.01 45.68 HEAD DEFORMITY | 1 0.01 45.69 HEAD INJURY | 7 0.07 45.76 HEADACHE | 75 0.75 46.51 HEARING IMPAIRED | 1 0.01 46.52 HEART INJURY | 1 0.01 46.53 HEART RATE | 1 0.01 46.54 HEART RATE ABNORMAL | 3 0.03 46.57 HEART RATE DECREASED | 6 0.06 46.63 HEART RATE INCREASED | 22 0.22 46.85 HEART RATE IRREGULAR | 5 0.05 46.90 HEART SOUNDS ABNORMAL | 1 0.01 46.91 HEART VALVE REPLACEMENT | 5 0.05 46.96 HEAT RASH | 1 0.01 46.97 HEMICEPHALALGIA | 1 0.01 46.98 HEMIPARESIS | 3 0.03 47.01 HEMIPLEGIA | 2 0.02 47.03 HEPARIN-INDUCED THROMBOCYTOPENIA | 2 0.02 47.05 HEPATIC CANCER STAGE IV | 1 0.01 47.06 HEPATIC CIRRHOSIS | 4 0.04 47.10 HEPATIC ENCEPHALOPATHY | 7 0.07 47.17 HEPATIC ENZYME ABNORMAL | 2 0.02 47.19 HEPATIC ENZYME INCREASED | 9 0.09 47.28 HEPATIC FAILURE | 10 0.10 47.38 HEPATIC FIBROSIS | 2 0.02 47.40 HEPATIC FUNCTION ABNORMAL | 19 0.19 47.59 HEPATIC NECROSIS | 1 0.01 47.60 HEPATIC NEOPLASM MALIGNANT | 4 0.04 47.64 HEPATIC STEATOSIS | 3 0.03 47.67 HEPATIC VEIN THROMBOSIS | 1 0.01 47.68 HEPATITIS | 12 0.12 47.80 HEPATITIS A | 1 0.01 47.81 HEPATITIS ACUTE | 1 0.01 47.82 HEPATITIS B | 2 0.02 47.84 HEPATITIS B ANTIBODY POSITIVE | 1 0.01 47.85 HEPATITIS C | 3 0.03 47.88 HEPATITIS CHOLESTATIC | 3 0.03 47.91 HEPATITIS FULMINANT | 3 0.03 47.94 HEPATITIS TOXIC | 2 0.02 47.96 HEPATOCELLULAR INJURY | 3 0.03 47.99 HEPATOMEGALY | 2 0.02 48.01 HEPATORENAL FAILURE | 1 0.01 48.02 HEPATOSPLENOMEGALY | 2 0.02 48.04 HEPATOTOXICITY | 1 0.01 48.05 HERNIA | 3 0.03 48.08 HERNIA REPAIR | 1 0.01 48.09 HERPES SIMPLEX | 1 0.01 48.10 HERPES VIRUS INFECTION | 3 0.03 48.13 HERPES ZOSTER | 5 0.05 48.18 HIATUS HERNIA | 7 0.07 48.25 HICCUPS | 2 0.02 48.27 HIGH FREQUENCY ABLATION | 1 0.01 48.28 HIP ARTHROPLASTY | 2 0.02 48.30 HIP DEFORMITY | 1 0.01 48.31 HIP FRACTURE | 15 0.15 48.46 HIP SURGERY | 1 0.01 48.47 HISTOPLASMOSIS DISSEMINATED | 1 0.01 48.48 HOMICIDAL IDEATION | 2 0.02 48.50 HOMICIDE | 1 0.01 48.51 HOSPITALISATION | 5 0.05 48.56 HOSTILITY | 2 0.02 48.58 HOT FLUSH | 8 0.08 48.66 HUMAN HERPESVIRUS 6 INFECTION | 1 0.01 48.67 HUMERUS FRACTURE | 1 0.01 48.68 HUNGER | 1 0.01 48.69 HYDRONEPHROSIS | 1 0.01 48.70 HYDROURETER | 1 0.01 48.71 HYPERACUSIS | 1 0.01 48.72 HYPERADRENALISM | 1 0.01 48.73 HYPERAEMIA | 2 0.02 48.75 HYPERAESTHESIA | 1 0.01 48.76 HYPERAMMONAEMIA | 1 0.01 48.77 HYPERAMMONAEMIC ENCEPHALOPATHY | 2 0.02 48.79 HYPERBILIRUBINAEMIA | 3 0.03 48.82 HYPERCALCAEMIA | 3 0.03 48.85 HYPERCHOLESTEROLAEMIA | 5 0.05 48.90 HYPERCREATINAEMIA | 1 0.01 48.91 HYPERGLYCAEMIA | 8 0.08 48.99 HYPERHIDROSIS | 21 0.21 49.20 HYPERKALAEMIA | 15 0.15 49.35 HYPERKERATOSIS | 1 0.01 49.36 HYPERLIPIDAEMIA | 6 0.06 49.42 HYPERPHOSPHATASAEMIA | 1 0.01 49.43 HYPERSENSITIVITY | 24 0.24 49.67 HYPERSOMNIA | 1 0.01 49.68 HYPERTENSION | 31 0.31 49.99 HYPERTENSIVE CRISIS | 1 0.01 50.00 HYPERTENSIVE EMERGENCY | 1 0.01 50.01 HYPERTENSIVE HEART DISEASE | 2 0.02 50.03 HYPERTHERMIA | 2 0.02 50.05 HYPERTHYROIDISM | 3 0.03 50.08 HYPERTONIA | 1 0.01 50.09 HYPERTONIC BLADDER | 1 0.01 50.10 HYPERTRIGLYCERIDAEMIA | 2 0.02 50.12 HYPERURICAEMIA | 2 0.02 50.14 HYPERVENTILATION | 1 0.01 50.15 HYPOAESTHESIA | 28 0.28 50.43 HYPOAESTHESIA EYE | 1 0.01 50.44 HYPOAESTHESIA FACIAL | 4 0.04 50.48 HYPOAESTHESIA ORAL | 5 0.05 50.53 HYPOALBUMINAEMIA | 4 0.04 50.57 HYPOGEUSIA | 1 0.01 50.58 HYPOGLYCAEMIA | 10 0.10 50.68 HYPOGLYCAEMIA UNAWARENESS | 1 0.01 50.69 HYPOGLYCAEMIC COMA | 1 0.01 50.70 HYPOGLYCAEMIC UNCONSCIOUSNESS | 4 0.04 50.74 HYPOKALAEMIA | 14 0.14 50.88 HYPOKINESIA | 6 0.06 50.94 HYPOMAGNESAEMIA | 1 0.01 50.95 HYPOMANIA | 1 0.01 50.96 HYPOMENORRHOEA | 3 0.03 50.99 HYPONATRAEMIA | 21 0.21 51.20 HYPOPARATHYROIDISM | 1 0.01 51.21 HYPOPHAGIA | 7 0.07 51.28 HYPOPHOSPHATAEMIA | 4 0.04 51.32 HYPOPLASTIC RIGHT HEART SYNDROME | 1 0.01 51.33 HYPOPROTEINAEMIA | 1 0.01 51.34 HYPOPROTHROMBINAEMIA | 2 0.02 51.36 HYPOSMIA | 2 0.02 51.38 HYPOTENSION | 31 0.31 51.69 HYPOTHERMIA | 5 0.05 51.74 HYPOTHYROIDISM | 6 0.06 51.80 HYPOTONIA | 3 0.03 51.83 HYPOTONIA NEONATAL | 1 0.01 51.84 HYPOVENTILATION | 1 0.01 51.85 HYPOVOLAEMIA | 2 0.02 51.87 HYPOVOLAEMIC SHOCK | 1 0.01 51.88 HYPOXIA | 4 0.04 51.92 HYSTERECTOMY | 1 0.01 51.93 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 51.94 IGA NEPHROPATHY | 2 0.02 51.96 IIIRD NERVE DISORDER | 1 0.01 51.97 ILEUS | 6 0.06 52.03 ILEUS PARALYTIC | 2 0.02 52.05 ILL-DEFINED DISORDER | 8 0.08 52.13 IMMUNE RECONSTITUTION SYNDROME | 1 0.01 52.14 IMMUNE SYSTEM DISORDER | 3 0.03 52.17 IMMUNODEFICIENCY | 1 0.01 52.18 IMMUNOSUPPRESSION | 1 0.01 52.19 IMPAIRED DRIVING ABILITY | 1 0.01 52.20 IMPAIRED GASTRIC EMPTYING | 3 0.03 52.23 IMPAIRED HEALING | 15 0.15 52.38 IMPAIRED WORK ABILITY | 8 0.08 52.46 IMPETIGO | 2 0.02 52.48 IMPLANTABLE DEFIBRILLATOR INSERTION | 1 0.01 52.49 IMPULSE-CONTROL DISORDER | 1 0.01 52.50 IMPULSIVE BEHAVIOUR | 1 0.01 52.51 INADEQUATE ANALGESIA | 2 0.02 52.53 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 2 0.02 52.55 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 5 0.05 52.60 INCISION SITE INFECTION | 1 0.01 52.61 INCISIONAL DRAINAGE | 1 0.01 52.62 INCOHERENT | 4 0.04 52.66 INCONTINENCE | 3 0.03 52.69 INCORRECT DOSE ADMINISTERED | 13 0.13 52.82 INCORRECT DRUG ADMINISTRATION RATE | 1 0.01 52.83 INCORRECT ROUTE OF DRUG ADMINISTRATION | 16 0.16 52.99 INCORRECT STORAGE OF DRUG | 9 0.09 53.08 INCREASED APPETITE | 7 0.07 53.15 INCREASED BRONCHIAL SECRETION | 2 0.02 53.17 INCREASED TENDENCY TO BRUISE | 3 0.03 53.20 INCREASED UPPER AIRWAY SECRETION | 4 0.04 53.24 INFARCTION | 1 0.01 53.25 INFECTION | 15 0.15 53.40 INFECTIOUS MONONUCLEOSIS | 1 0.01 53.41 INFERTILITY | 1 0.01 53.42 INFLAMMATION | 8 0.08 53.50 INFLAMMATORY BOWEL DISEASE | 3 0.03 53.53 INFLUENZA | 10 0.10 53.63 INFLUENZA LIKE ILLNESS | 12 0.12 53.75 INFREQUENT BOWEL MOVEMENTS | 1 0.01 53.76 INFUSION RELATED REACTION | 8 0.08 53.84 INGROWING NAIL | 1 0.01 53.85 INGROWN HAIR | 2 0.02 53.87 INHIBITORY DRUG INTERACTION | 1 0.01 53.88 INJECTION SITE COLDNESS | 1 0.01 53.89 INJECTION SITE DISCHARGE | 1 0.01 53.90 INJECTION SITE DISCOLOURATION | 2 0.02 53.92 INJECTION SITE ERYTHEMA | 4 0.04 53.96 INJECTION SITE EXTRAVASATION | 9 0.09 54.05 INJECTION SITE HAEMATOMA | 6 0.06 54.11 INJECTION SITE HAEMORRHAGE | 3 0.03 54.14 INJECTION SITE INDURATION | 1 0.01 54.15 INJECTION SITE INJURY | 3 0.03 54.18 INJECTION SITE NECROSIS | 2 0.02 54.20 INJECTION SITE OEDEMA | 1 0.01 54.21 INJECTION SITE PAIN | 7 0.07 54.28 INJECTION SITE PRURITUS | 2 0.02 54.30 INJECTION SITE REACTION | 3 0.03 54.33 INJECTION SITE SWELLING | 2 0.02 54.35 INJECTION SITE URTICARIA | 2 0.02 54.37 INJURY | 12 0.12 54.49 INSOMNIA | 44 0.44 54.93 INSPIRATORY CAPACITY DECREASED | 1 0.01 54.94 INSULIN-LIKE GROWTH FACTOR INCREASED | 1 0.01 54.95 INTENTION TREMOR | 1 0.01 54.96 INTENTIONAL DRUG MISUSE | 7 0.07 55.03 INTENTIONAL OVERDOSE | 7 0.07 55.10 INTENTIONAL SELF-INJURY | 1 0.01 55.11 INTERCOSTAL NEURALGIA | 1 0.01 55.12 INTERLEUKIN LEVEL INCREASED | 1 0.01 55.13 INTERNATIONAL NORMALISED RATIO INCREA.. | 14 0.14 55.27 INTERSTITIAL LUNG DISEASE | 16 0.16 55.43 INTERVERTEBRAL DISC DEGENERATION | 2 0.02 55.45 INTERVERTEBRAL DISC DISORDER | 2 0.02 55.47 INTERVERTEBRAL DISC OPERATION | 2 0.02 55.49 INTERVERTEBRAL DISC PROTRUSION | 5 0.05 55.54 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 55.55 INTESTINAL HAEMORRHAGE | 1 0.01 55.56 INTESTINAL MASS | 1 0.01 55.57 INTESTINAL OBSTRUCTION | 7 0.07 55.64 INTESTINAL OPERATION | 1 0.01 55.65 INTESTINAL RESECTION | 2 0.02 55.67 INTESTINAL STENOSIS | 1 0.01 55.68 INTRA-ABDOMINAL HAEMATOMA | 2 0.02 55.70 INTRA-ABDOMINAL HAEMORRHAGE | 1 0.01 55.71 INTRA-UTERINE DEATH | 1 0.01 55.72 INTRACRANIAL ANEURYSM | 1 0.01 55.73 INTRACRANIAL PRESSURE INCREASED | 2 0.02 55.75 INTRACRANIAL VENOUS SINUS THROMBOSIS | 1 0.01 55.76 INTRAOCULAR PRESSURE INCREASED | 4 0.04 55.80 IRIS ADHESIONS | 1 0.01 55.81 IRITIS | 1 0.01 55.82 IRON BINDING CAPACITY TOTAL DECREASED | 1 0.01 55.83 IRON DEFICIENCY | 1 0.01 55.84 IRON DEFICIENCY ANAEMIA | 1 0.01 55.85 IRON OVERLOAD | 1 0.01 55.86 IRRITABILITY | 10 0.10 55.96 IRRITABLE BOWEL SYNDROME | 4 0.04 56.00 ISCHAEMIA | 3 0.03 56.03 ISCHAEMIC STROKE | 2 0.02 56.05 ISCHAEMIC ULCER | 1 0.01 56.06 JAUNDICE | 10 0.10 56.16 JAUNDICE CHOLESTATIC | 3 0.03 56.19 JAW DISORDER | 3 0.03 56.22 JAW FRACTURE | 2 0.02 56.24 JAW OPERATION | 1 0.01 56.25 JESSNER'S LYMPHOCYTIC INFILTRATION | 1 0.01 56.26 JOINT ANKYLOSIS | 2 0.02 56.28 JOINT CREPITATION | 1 0.01 56.29 JOINT DISLOCATION | 1 0.01 56.30 JOINT LOCK | 1 0.01 56.31 JOINT RANGE OF MOTION DECREASED | 4 0.04 56.35 JOINT SPRAIN | 3 0.03 56.38 JOINT STIFFNESS | 3 0.03 56.41 JOINT SWELLING | 13 0.13 56.54 JUVENILE ARTHRITIS | 1 0.01 56.55 KAWASAKI'S DISEASE | 1 0.01 56.56 KERATITIS | 2 0.02 56.58 KETOACIDOSIS | 2 0.02 56.60 KETOSIS | 1 0.01 56.61 KIDNEY INFECTION | 2 0.02 56.63 KIDNEY TRANSPLANT REJECTION | 2 0.02 56.65 KLEBSIELLA INFECTION | 1 0.01 56.66 KNEE ARTHROPLASTY | 5 0.05 56.71 KNEE OPERATION | 1 0.01 56.72 KOEPPE NODULES | 1 0.01 56.73 LABILE BLOOD PRESSURE | 1 0.01 56.74 LABORATORY TEST ABNORMAL | 1 0.01 56.75 LABYRINTHITIS | 1 0.01 56.76 LACRIMATION INCREASED | 5 0.05 56.81 LACTIC ACIDOSIS | 3 0.03 56.84 LARGE GRANULAR LYMPHOCYTOSIS | 1 0.01 56.85 LARGE INTESTINAL ULCER | 1 0.01 56.86 LARGE INTESTINE ANASTOMOSIS | 1 0.01 56.87 LARGE INTESTINE OPERATION | 1 0.01 56.88 LARGE INTESTINE PERFORATION | 8 0.08 56.96 LARYNGEAL OEDEMA | 2 0.02 56.98 LARYNGITIS | 2 0.02 57.00 LEFT ATRIAL DILATATION | 1 0.01 57.01 LEFT VENTRICULAR DYSFUNCTION | 2 0.02 57.03 LEFT VENTRICULAR HYPERTROPHY | 1 0.01 57.04 LENTICULAR OPACITIES | 1 0.01 57.05 LETHARGY | 11 0.11 57.16 LEUKAEMIA | 1 0.01 57.17 LEUKOCYTOCLASTIC VASCULITIS | 1 0.01 57.18 LEUKOCYTOSIS | 7 0.07 57.25 LEUKOENCEPHALOPATHY | 3 0.03 57.28 LEUKOPENIA | 7 0.07 57.35 LEUKOPLAKIA ORAL | 1 0.01 57.36 LIBIDO DECREASED | 4 0.04 57.40 LIBIDO INCREASED | 1 0.01 57.41 LICHEN PLANUS | 2 0.02 57.43 LICHENOID KERATOSIS | 1 0.01 57.44 LIGAMENT DISORDER | 1 0.01 57.45 LIMB DEFORMITY | 1 0.01 57.46 LIMB INJURY | 2 0.02 57.48 LIMB OPERATION | 1 0.01 57.49 LIP DISORDER | 2 0.02 57.51 LIP DRY | 2 0.02 57.53 LIP HAEMORRHAGE | 1 0.01 57.54 LIP SWELLING | 7 0.07 57.61 LIP ULCERATION | 1 0.01 57.62 LIPASE INCREASED | 3 0.03 57.65 LIPIDS INCREASED | 1 0.01 57.66 LISTLESS | 2 0.02 57.68 LIVE BIRTH | 1 0.01 57.69 LIVER ABSCESS | 2 0.02 57.71 LIVER CARCINOMA RUPTURED | 1 0.01 57.72 LIVER DISORDER | 22 0.22 57.94 LIVER FUNCTION TEST ABNORMAL | 18 0.18 58.12 LIVER INJURY | 3 0.03 58.15 LIVER TRANSPLANT | 2 0.02 58.17 LIVER TRANSPLANT REJECTION | 1 0.01 58.18 LIVING IN RESIDENTIAL INSTITUTION | 1 0.01 58.19 LOCAL SWELLING | 4 0.04 58.23 LOCALISED OEDEMA | 1 0.01 58.24 LOCKED-IN SYNDROME | 1 0.01 58.25 LOGORRHOEA | 1 0.01 58.26 LONG QT SYNDROME | 1 0.01 58.27 LOSS OF CONSCIOUSNESS | 49 0.49 58.76 LOSS OF CONTROL OF LEGS | 1 0.01 58.77 LOSS OF LIBIDO | 2 0.02 58.79 LOSS OF PROPRIOCEPTION | 1 0.01 58.80 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 58.81 LOWER LIMB FRACTURE | 5 0.05 58.86 LOWER RESPIRATORY TRACT INFECTION | 4 0.04 58.90 LOWER RESPIRATORY TRACT INFECTION BAC.. | 2 0.02 58.92 LUMBAR SPINAL STENOSIS | 1 0.01 58.93 LUMBAR VERTEBRAL FRACTURE | 1 0.01 58.94 LUNG ADENOCARCINOMA | 1 0.01 58.95 LUNG CONSOLIDATION | 1 0.01 58.96 LUNG DISORDER | 13 0.13 59.09 LUNG INDURATION | 1 0.01 59.10 LUNG INFECTION | 3 0.03 59.13 LUNG INFECTION PSEUDOMONAL | 1 0.01 59.14 LUNG INFILTRATION | 3 0.03 59.17 LUNG NEOPLASM | 2 0.02 59.19 LUNG NEOPLASM MALIGNANT | 12 0.12 59.31 LUPUS NEPHRITIS | 1 0.01 59.32 LUPUS-LIKE SYNDROME | 1 0.01 59.33 LYMPH NODE TUBERCULOSIS | 1 0.01 59.34 LYMPHADENOPATHY | 6 0.06 59.40 LYMPHOCYTE COUNT DECREASED | 5 0.05 59.45 LYMPHOCYTE PERCENTAGE INCREASED | 1 0.01 59.46 LYMPHOCYTOSIS | 1 0.01 59.47 LYMPHOEDEMA | 2 0.02 59.49 LYMPHOMA | 3 0.03 59.52 LYMPHOPENIA | 6 0.06 59.58 LYMPHOPROLIFERATIVE DISORDER | 1 0.01 59.59 MACULAR DEGENERATION | 2 0.02 59.61 MACULAR OEDEMA | 2 0.02 59.63 MACULOPATHY | 1 0.01 59.64 MAJOR DEPRESSION | 1 0.01 59.65 MALABSORPTION | 1 0.01 59.66 MALAISE | 54 0.54 60.20 MALIGNANT MELANOMA | 3 0.03 60.23 MALIGNANT NEOPLASM PROGRESSION | 22 0.22 60.45 MALIGNANT PLEURAL EFFUSION | 1 0.01 60.46 MALIGNANT TUMOUR EXCISION | 1 0.01 60.47 MALNUTRITION | 3 0.03 60.50 MANIA | 6 0.06 60.56 MANTLE CELL LYMPHOMA | 1 0.01 60.57 MARASMUS | 1 0.01 60.58 MASS | 2 0.02 60.60 MASTITIS | 2 0.02 60.62 MATERNAL DRUGS AFFECTING FOETUS | 1 0.01 60.63 MEAN CELL HAEMOGLOBIN INCREASED | 2 0.02 60.65 MEAN CELL VOLUME INCREASED | 1 0.01 60.66 MEAN PLATELET VOLUME DECREASED | 1 0.01 60.67 MECHANICAL VENTILATION | 7 0.07 60.74 MEDICAL DEVICE COMPLICATION | 24 0.24 60.98 MEDICAL DEVICE IMPLANTATION | 1 0.01 60.99 MEDICATION ERROR | 6 0.06 61.05 MEDICATION RESIDUE | 1 0.01 61.06 MELAENA | 16 0.16 61.22 MELANOCYTIC NAEVUS | 1 0.01 61.23 MEMORY IMPAIRMENT | 18 0.18 61.41 MENINGIOMA | 1 0.01 61.42 MENINGITIS ASEPTIC | 1 0.01 61.43 MENINGITIS BACTERIAL | 1 0.01 61.44 MENINGITIS ENTEROVIRAL | 1 0.01 61.45 MENINGOMYELOCELE | 2 0.02 61.47 MENISCUS LESION | 1 0.01 61.48 MENORRHAGIA | 9 0.09 61.57 MENSTRUAL DISORDER | 2 0.02 61.59 MENSTRUATION DELAYED | 8 0.08 61.67 MENSTRUATION IRREGULAR | 3 0.03 61.70 MENTAL DISORDER | 9 0.09 61.79 MENTAL IMPAIRMENT | 3 0.03 61.82 MENTAL STATUS CHANGES | 10 0.10 61.92 METABOLIC ACIDOSIS | 2 0.02 61.94 METABOLIC DISORDER | 1 0.01 61.95 METAMORPHOPSIA | 1 0.01 61.96 METASTASES TO CENTRAL NERVOUS SYSTEM | 2 0.02 61.98 METASTASES TO KIDNEY | 1 0.01 61.99 METASTASES TO LIVER | 2 0.02 62.01 METASTASES TO MENINGES | 2 0.02 62.03 METASTASES TO PERITONEUM | 1 0.01 62.04 METASTASES TO SPINE | 1 0.01 62.05 METASTASES TO SPLEEN | 1 0.01 62.06 METASTATIC NEOPLASM | 3 0.03 62.09 METATARSALGIA | 1 0.01 62.10 METHAEMOGLOBINAEMIA | 2 0.02 62.12 METRORRHAGIA | 4 0.04 62.16 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA | 1 0.01 62.17 MICROCYTIC ANAEMIA | 1 0.01 62.18 MICTURITION FREQUENCY DECREASED | 1 0.01 62.19 MICTURITION URGENCY | 2 0.02 62.21 MIDDLE INSOMNIA | 3 0.03 62.24 MIGRAINE | 6 0.06 62.30 MILIA | 1 0.01 62.31 MILK ALLERGY | 1 0.01 62.32 MITOCHONDRIAL TOXICITY | 2 0.02 62.34 MITRAL VALVE REPAIR | 1 0.01 62.35 MOBILITY DECREASED | 11 0.11 62.46 MONARTHRITIS | 1 0.01 62.47 MONOCYTE COUNT INCREASED | 1 0.01 62.48 MONOCYTE PERCENTAGE INCREASED | 1 0.01 62.49 MONONUCLEOSIS SYNDROME | 1 0.01 62.50 MONOPARESIS | 1 0.01 62.51 MONOPLEGIA | 1 0.01 62.52 MOOD ALTERED | 6 0.06 62.58 MOOD SWINGS | 7 0.07 62.65 MORBID THOUGHTS | 2 0.02 62.67 MOUTH HAEMORRHAGE | 2 0.02 62.69 MOUTH ULCERATION | 4 0.04 62.73 MOVEMENT DISORDER | 2 0.02 62.75 MUCORMYCOSIS | 1 0.01 62.76 MUCOSAL INFLAMMATION | 4 0.04 62.80 MUCOUS MEMBRANE DISORDER | 1 0.01 62.81 MULTI-ORGAN DISORDER | 2 0.02 62.83 MULTI-ORGAN FAILURE | 13 0.13 62.96 MULTIPLE DRUG OVERDOSE | 3 0.03 62.99 MULTIPLE INJURIES | 1 0.01 63.00 MULTIPLE MYELOMA | 5 0.05 63.05 MULTIPLE SCLEROSIS | 12 0.12 63.17 MULTIPLE SCLEROSIS RELAPSE | 15 0.15 63.32 MUSCLE ATROPHY | 2 0.02 63.34 MUSCLE CONTRACTURE | 1 0.01 63.35 MUSCLE DISORDER | 2 0.02 63.37 MUSCLE HAEMORRHAGE | 1 0.01 63.38 MUSCLE RIGIDITY | 1 0.01 63.39 MUSCLE RUPTURE | 1 0.01 63.40 MUSCLE SPASMS | 30 0.30 63.70 MUSCLE SPASTICITY | 1 0.01 63.71 MUSCLE STRAIN | 1 0.01 63.72 MUSCLE TIGHTNESS | 2 0.02 63.74 MUSCLE TWITCHING | 1 0.01 63.75 MUSCULAR WEAKNESS | 25 0.25 64.00 MUSCULOSKELETAL CHEST PAIN | 5 0.05 64.05 MUSCULOSKELETAL DISCOMFORT | 2 0.02 64.07 MUSCULOSKELETAL DISORDER | 1 0.01 64.08 MUSCULOSKELETAL PAIN | 8 0.08 64.16 MUSCULOSKELETAL STIFFNESS | 11 0.11 64.27 MYALGIA | 31 0.31 64.58 MYASTHENIA GRAVIS | 1 0.01 64.59 MYCOBACTERIUM TEST POSITIVE | 1 0.01 64.60 MYCOSIS FUNGOIDES | 1 0.01 64.61 MYDRIASIS | 4 0.04 64.65 MYELITIS TRANSVERSE | 1 0.01 64.66 MYELODYSPLASTIC SYNDROME | 3 0.03 64.69 MYELOFIBROSIS | 2 0.02 64.71 MYELOPATHY | 1 0.01 64.72 MYOCARDIAL INFARCTION | 41 0.41 65.13 MYOCARDIAL ISCHAEMIA | 4 0.04 65.17 MYOCLONUS | 1 0.01 65.18 MYOPATHY | 7 0.07 65.25 MYOSITIS | 1 0.01 65.26 NAIL BED BLEEDING | 1 0.01 65.27 NAIL DISCOLOURATION | 1 0.01 65.28 NAIL DISORDER | 1 0.01 65.29 NAIL INFECTION | 1 0.01 65.30 NARCOTIC INTOXICATION | 1 0.01 65.31 NASAL CONGESTION | 4 0.04 65.35 NASAL DRYNESS | 1 0.01 65.36 NASAL OEDEMA | 1 0.01 65.37 NASAL POLYPS | 1 0.01 65.38 NASAL SEPTUM DEVIATION | 1 0.01 65.39 NASAL SEPTUM PERFORATION | 2 0.02 65.41 NASOPHARYNGITIS | 11 0.11 65.52 NAUSEA | 125 1.25 66.77 NECK MASS | 1 0.01 66.78 NECK PAIN | 11 0.11 66.89 NEEDLE ISSUE | 1 0.01 66.90 NEONATAL HYPONATRAEMIA | 1 0.01 66.91 NEONATAL RESPIRATORY ARREST | 2 0.02 66.93 NEOPLASM | 2 0.02 66.95 NEOPLASM MALIGNANT | 3 0.03 66.98 NEOPLASM OF APPENDIX | 1 0.01 66.99 NEOPLASM PROGRESSION | 1 0.01 67.00 NEOPLASM RECURRENCE | 2 0.02 67.02 NEPHRECTOMY | 1 0.01 67.03 NEPHRITIS | 3 0.03 67.06 NEPHROCALCINOSIS | 1 0.01 67.07 NEPHROGENIC SYSTEMIC FIBROSIS | 12 0.12 67.19 NEPHROLITHIASIS | 8 0.08 67.27 NEPHROPATHY | 3 0.03 67.30 NEPHROSCLEROSIS | 1 0.01 67.31 NEPHROSTOMY | 1 0.01 67.32 NEPHROTIC SYNDROME | 2 0.02 67.34 NERVE COMPRESSION | 1 0.01 67.35 NERVE INJURY | 1 0.01 67.36 NERVE ROOT COMPRESSION | 1 0.01 67.37 NERVOUS SYSTEM DISORDER | 3 0.03 67.40 NERVOUSNESS | 8 0.08 67.48 NEURALGIA | 4 0.04 67.52 NEURITIS | 1 0.01 67.53 NEURITIS CRANIAL | 1 0.01 67.54 NEUROGENIC BLADDER | 1 0.01 67.55 NEUROLEPTIC MALIGNANT SYNDROME | 1 0.01 67.56 NEUROLOGICAL DECOMPENSATION | 2 0.02 67.58 NEUROLOGICAL SYMPTOM | 1 0.01 67.59 NEUROPATHY PERIPHERAL | 14 0.14 67.73 NEUROPSYCHIATRIC LUPUS | 1 0.01 67.74 NEUROSIS | 1 0.01 67.75 NEUROTOXICITY | 1 0.01 67.76 NEUTRALISING ANTIBODIES POSITIVE | 1 0.01 67.77 NEUTROPENIA | 29 0.29 68.06 NEUTROPHIL COUNT DECREASED | 9 0.09 68.15 NEUTROPHIL COUNT INCREASED | 8 0.08 68.23 NEUTROPHIL PERCENTAGE DECREASED | 1 0.01 68.24 NIGHT SWEATS | 1 0.01 68.25 NIGHTMARE | 6 0.06 68.31 NIPPLE PAIN | 1 0.01 68.32 NO ADVERSE EVENT | 17 0.17 68.49 NO THERAPEUTIC RESPONSE | 9 0.09 68.58 NOCTURIA | 4 0.04 68.62 NODULE | 1 0.01 68.63 NODULE ON EXTREMITY | 1 0.01 68.64 NON-HODGKIN'S LYMPHOMA | 1 0.01 68.65 NON-SMALL CELL LUNG CANCER METASTATIC | 1 0.01 68.66 NORMAL NEWBORN | 1 0.01 68.67 NUCHAL RIGIDITY | 1 0.01 68.68 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 1 0.01 68.69 NYSTAGMUS | 1 0.01 68.70 OBESITY | 2 0.02 68.72 OBESITY SURGERY | 1 0.01 68.73 OBLITERATIVE BRONCHIOLITIS | 1 0.01 68.74 OBSESSIVE THOUGHTS | 1 0.01 68.75 OBSESSIVE-COMPULSIVE DISORDER | 3 0.03 68.78 OBSTRUCTIVE AIRWAYS DISORDER | 1 0.01 68.79 OCCULT BLOOD | 1 0.01 68.80 OCCULT BLOOD POSITIVE | 2 0.02 68.82 OCULAR HYPERAEMIA | 7 0.07 68.89 OCULAR HYPERTENSION | 1 0.01 68.90 OCULAR ICTERUS | 2 0.02 68.92 ODYNOPHAGIA | 3 0.03 68.95 OEDEMA | 9 0.09 69.04 OEDEMA MOUTH | 3 0.03 69.07 OEDEMA PERIPHERAL | 44 0.44 69.51 OESOPHAGEAL CANDIDIASIS | 1 0.01 69.52 OESOPHAGEAL CARCINOMA | 1 0.01 69.53 OESOPHAGEAL DISCOMFORT | 1 0.01 69.54 OESOPHAGEAL HAEMORRHAGE | 2 0.02 69.56 OESOPHAGEAL MASS | 1 0.01 69.57 OESOPHAGEAL RUPTURE | 1 0.01 69.58 OESOPHAGEAL SQUAMOUS CELL CARCINOMA | 1 0.01 69.59 OESOPHAGEAL ULCER | 4 0.04 69.63 OESOPHAGEAL VARICES HAEMORRHAGE | 1 0.01 69.64 OESOPHAGITIS | 8 0.08 69.72 OFF LABEL USE | 17 0.17 69.89 OLIGOHYDRAMNIOS | 3 0.03 69.92 OLIGOMENORRHOEA | 1 0.01 69.93 ONYCHOCLASIS | 1 0.01 69.94 ONYCHOMADESIS | 2 0.02 69.96 OPEN ANGLE GLAUCOMA | 1 0.01 69.97 OPEN WOUND | 2 0.02 69.99 OPERATIVE HAEMORRHAGE | 1 0.01 70.00 OPHTHALMOPLEGIA | 1 0.01 70.01 OPISTHOTONUS | 2 0.02 70.03 OPPOSITIONAL DEFIANT DISORDER | 1 0.01 70.04 OPTIC ISCHAEMIC NEUROPATHY | 1 0.01 70.05 OPTIC NEURITIS | 2 0.02 70.07 ORAL DISORDER | 7 0.07 70.14 ORAL FUNGAL INFECTION | 1 0.01 70.15 ORAL HERPES | 1 0.01 70.16 ORAL INFECTION | 1 0.01 70.17 ORAL MUCOSA EROSION | 1 0.01 70.18 ORAL MUCOSAL DISCOLOURATION | 1 0.01 70.19 ORAL PAIN | 2 0.02 70.21 ORAL PRURITUS | 1 0.01 70.22 ORAL SURGERY | 1 0.01 70.23 ORAL TORUS | 1 0.01 70.24 ORGAN FAILURE | 6 0.06 70.30 ORGANISING PNEUMONIA | 1 0.01 70.31 OROMANDIBULAR DYSTONIA | 1 0.01 70.32 OROPHARYNGEAL BLISTERING | 1 0.01 70.33 OROPHARYNGEAL CANDIDIASIS | 2 0.02 70.35 OROPHARYNGEAL DISCOMFORT | 2 0.02 70.37 OROPHARYNGEAL PAIN | 8 0.08 70.45 OROPHARYNGEAL SWELLING | 1 0.01 70.46 ORTHOPEDIC PROCEDURE | 1 0.01 70.47 ORTHOPNOEA | 1 0.01 70.48 ORTHOSTATIC HYPOTENSION | 1 0.01 70.49 OSTEITIS | 1 0.01 70.50 OSTEOARTHRITIS | 4 0.04 70.54 OSTEOLYSIS | 1 0.01 70.55 OSTEOMALACIA | 1 0.01 70.56 OSTEOMYELITIS | 5 0.05 70.61 OSTEOMYELITIS CHRONIC | 1 0.01 70.62 OSTEONECROSIS | 41 0.41 71.03 OSTEOPENIA | 2 0.02 71.05 OSTEOPOROSIS | 6 0.06 71.11 OSTEOPOROTIC FRACTURE | 1 0.01 71.12 OTITIS MEDIA | 1 0.01 71.13 OVARIAN CANCER | 4 0.04 71.17 OVARIAN CYST | 3 0.03 71.20 OVARIAN CYST RUPTURED | 1 0.01 71.21 OVARIAN EPITHELIAL CANCER | 1 0.01 71.22 OVARIAN HAEMATOMA | 1 0.01 71.23 OVARIAN NEOPLASM | 1 0.01 71.24 OVERDOSE | 31 0.31 71.55 OXYGEN SATURATION DECREASED | 10 0.10 71.65 PAIN | 97 0.97 72.62 PAIN IN EXTREMITY | 49 0.49 73.11 PAIN IN JAW | 7 0.07 73.18 PAIN OF SKIN | 3 0.03 73.21 PALLOR | 5 0.05 73.26 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 17 0.17 73.43 PALPITATIONS | 19 0.19 73.62 PANCREATIC CARCINOMA | 1 0.01 73.63 PANCREATIC CYST | 1 0.01 73.64 PANCREATIC DISORDER | 2 0.02 73.66 PANCREATIC ENZYMES INCREASED | 1 0.01 73.67 PANCREATITIS | 12 0.12 73.79 PANCREATITIS ACUTE | 5 0.05 73.84 PANCYTOPENIA | 11 0.11 73.95 PANIC ATTACK | 5 0.05 74.00 PANIC DISORDER | 1 0.01 74.01 PANIC REACTION | 3 0.03 74.04 PAPILLITIS | 1 0.01 74.05 PAPILLOEDEMA | 5 0.05 74.10 PAPILLOMA | 1 0.01 74.11 PARAESTHESIA | 28 0.28 74.39 PARAESTHESIA ORAL | 2 0.02 74.41 PARALYSIS | 6 0.06 74.47 PARANOIA | 1 0.01 74.48 PARKINSON'S DISEASE | 3 0.03 74.51 PARKINSONISM | 10 0.10 74.61 PARONYCHIA | 1 0.01 74.62 PAROSMIA | 2 0.02 74.64 PARTIAL SEIZURES | 1 0.01 74.65 PATELLA FRACTURE | 1 0.01 74.66 PATHOGEN RESISTANCE | 3 0.03 74.69 PATHOLOGICAL FRACTURE | 1 0.01 74.70 PELIOSIS HEPATIS | 1 0.01 74.71 PELVIC FRACTURE | 5 0.05 74.76 PELVIC HAEMATOMA | 1 0.01 74.77 PELVIC INFLAMMATORY DISEASE | 1 0.01 74.78 PELVIC KIDNEY | 1 0.01 74.79 PELVIC PAIN | 5 0.05 74.84 PENILE SWELLING | 1 0.01 74.85 PENIS DISORDER | 1 0.01 74.86 PEPTIC ULCER | 1 0.01 74.87 PERCUTANEOUS CORONARY INTERVENTION | 2 0.02 74.89 PERFORMANCE STATUS DECREASED | 3 0.03 74.92 PERICARDIAL EFFUSION | 2 0.02 74.94 PERICARDITIS | 1 0.01 74.95 PERIODONTAL DISEASE | 3 0.03 74.98 PERIODONTAL OPERATION | 1 0.01 74.99 PERIODONTITIS | 2 0.02 75.01 PERIORBITAL CELLULITIS | 1 0.01 75.02 PERIORBITAL HAEMATOMA | 1 0.01 75.03 PERIORBITAL OEDEMA | 2 0.02 75.05 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 1 0.01 75.06 PERIPHERAL COLDNESS | 2 0.02 75.08 PERIPHERAL EMBOLISM | 1 0.01 75.09 PERIPHERAL ISCHAEMIA | 2 0.02 75.11 PERIPHERAL NERVE DECOMPRESSION | 1 0.01 75.12 PERIPHERAL SENSORY NEUROPATHY | 1 0.01 75.13 PERIPHERAL VASCULAR DISORDER | 2 0.02 75.15 PERITONEAL DISORDER | 1 0.01 75.16 PERITONEAL HAEMORRHAGE | 1 0.01 75.17 PERITONITIS | 3 0.03 75.20 PERITONITIS BACTERIAL | 1 0.01 75.21 PERITONSILLAR ABSCESS | 1 0.01 75.22 PERNICIOUS ANAEMIA | 1 0.01 75.23 PERONEAL NERVE PALSY | 3 0.03 75.26 PERSONALITY CHANGE | 3 0.03 75.29 PETECHIAE | 4 0.04 75.33 PHARYNGEAL ERYTHEMA | 1 0.01 75.34 PHARYNGEAL HAEMORRHAGE | 1 0.01 75.35 PHARYNGEAL NEOPLASM | 1 0.01 75.36 PHARYNGEAL OEDEMA | 6 0.06 75.42 PHARYNGITIS | 5 0.05 75.47 PHARYNGITIS STREPTOCOCCAL | 1 0.01 75.48 PHLEBITIS | 3 0.03 75.51 PHLEBOTOMY | 2 0.02 75.53 PHOTODERMATOSIS | 1 0.01 75.54 PHOTOPHOBIA | 2 0.02 75.56 PHOTOSENSITIVITY REACTION | 3 0.03 75.59 PHYSICAL ASSAULT | 1 0.01 75.60 PHYSICAL EXAMINATION ABNORMAL | 1 0.01 75.61 PIGMENTATION DISORDER | 1 0.01 75.62 PITUITARY TUMOUR | 1 0.01 75.63 PLACENTA PRAEVIA | 1 0.01 75.64 PLANTAR FASCIITIS | 1 0.01 75.65 PLASMACYTOMA | 1 0.01 75.66 PLATELET COUNT DECREASED | 28 0.28 75.94 PLATELET COUNT INCREASED | 4 0.04 75.98 PLATELET TOXICITY | 1 0.01 75.99 PLEURAL EFFUSION | 7 0.07 76.06 PLEURISY | 1 0.01 76.07 PNEUMOCYSTIS JIROVECI PNEUMONIA | 12 0.12 76.19 PNEUMOMEDIASTINUM | 2 0.02 76.21 PNEUMONIA | 47 0.47 76.68 PNEUMONIA ASPIRATION | 5 0.05 76.73 PNEUMONIA BACTERIAL | 2 0.02 76.75 PNEUMONIA CRYPTOCOCCAL | 1 0.01 76.76 PNEUMONIA FUNGAL | 1 0.01 76.77 PNEUMONIA INFLUENZAL | 1 0.01 76.78 PNEUMONIA PNEUMOCOCCAL | 1 0.01 76.79 PNEUMONITIS | 2 0.02 76.81 POISONING | 2 0.02 76.83 POISONING DELIBERATE | 2 0.02 76.85 POLLAKIURIA | 11 0.11 76.96 POLYARTHRITIS | 2 0.02 76.98 POLYMENORRHOEA | 1 0.01 76.99 POLYNEUROPATHY | 2 0.02 77.01 POLYNEUROPATHY IDIOPATHIC PROGRESSIVE | 1 0.01 77.02 POLYP | 1 0.01 77.03 POLYURIA | 1 0.01 77.04 POOR PERIPHERAL CIRCULATION | 2 0.02 77.06 POOR QUALITY DRUG ADMINISTERED | 11 0.11 77.17 POOR QUALITY SLEEP | 1 0.01 77.18 POOR VENOUS ACCESS | 1 0.01 77.19 PORTAL HYPERTENSION | 1 0.01 77.20 PORTAL VEIN THROMBOSIS | 1 0.01 77.21 POST HERPETIC NEURALGIA | 1 0.01 77.22 POST LUMBAR PUNCTURE SYNDROME | 2 0.02 77.24 POST POLIO SYNDROME | 1 0.01 77.25 POST PROCEDURAL COMPLICATION | 1 0.01 77.26 POST PROCEDURAL HAEMORRHAGE | 2 0.02 77.28 POST PROCEDURAL SEPSIS | 1 0.01 77.29 POST PROCEDURAL SWELLING | 1 0.01 77.30 POST-TRAUMATIC STRESS DISORDER | 1 0.01 77.31 POSTICTAL STATE | 1 0.01 77.32 POSTNASAL DRIP | 1 0.01 77.33 POSTOPERATIVE FEVER | 1 0.01 77.34 POSTURE ABNORMAL | 2 0.02 77.36 POTENTIATING DRUG INTERACTION | 1 0.01 77.37 PREGNANCY | 7 0.07 77.44 PREGNANCY ON ORAL CONTRACEPTIVE | 8 0.08 77.52 PREGNANCY WITH CONTRACEPTIVE DEVICE | 12 0.12 77.64 PREMATURE BABY | 7 0.07 77.71 PREMATURE LABOUR | 2 0.02 77.73 PRESBYACUSIS | 1 0.01 77.74 PRESYNCOPE | 9 0.09 77.83 PRIMARY HYPERALDOSTERONISM | 1 0.01 77.84 PRIMARY SEQUESTRUM | 2 0.02 77.86 PROCEDURAL COMPLICATION | 1 0.01 77.87 PROCEDURAL HYPOTENSION | 2 0.02 77.89 PROCEDURAL PAIN | 8 0.08 77.97 PROCTALGIA | 1 0.01 77.98 PROCTITIS | 1 0.01 77.99 PROCTITIS ULCERATIVE | 1 0.01 78.00 PROCTOCOLITIS | 1 0.01 78.01 PRODUCT ADHESION ISSUE | 6 0.06 78.07 PRODUCT CONTAMINATION | 1 0.01 78.08 PRODUCT COUNTERFEIT | 1 0.01 78.09 PRODUCT MEASURED POTENCY ISSUE | 1 0.01 78.10 PRODUCT PACKAGING QUANTITY ISSUE | 3 0.03 78.13 PRODUCT QUALITY ISSUE | 44 0.44 78.57 PRODUCT SIZE ISSUE | 1 0.01 78.58 PRODUCT SUBSTITUTION ISSUE | 27 0.27 78.85 PRODUCTIVE COUGH | 4 0.04 78.89 PROGESTERONE DECREASED | 1 0.01 78.90 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 1 0.01 78.91 PROPOFOL INFUSION SYNDROME | 3 0.03 78.94 PROSTATE CANCER | 5 0.05 78.99 PROSTATE CANCER METASTATIC | 1 0.01 79.00 PROSTATIC OPERATION | 1 0.01 79.01 PROSTATIC SPECIFIC ANTIGEN DECREASED | 1 0.01 79.02 PROSTATIC SPECIFIC ANTIGEN INCREASED | 4 0.04 79.06 PROSTATITIS | 1 0.01 79.07 PROSTATOMEGALY | 2 0.02 79.09 PROSTHESIS USER | 1 0.01 79.10 PROTEIN TOTAL DECREASED | 2 0.02 79.12 PROTEIN URINE PRESENT | 2 0.02 79.14 PROTEINURIA | 5 0.05 79.19 PROTHROMBIN TIME PROLONGED | 1 0.01 79.20 PROTHROMBIN TIME SHORTENED | 1 0.01 79.21 PRURITUS | 42 0.42 79.63 PRURITUS GENERALISED | 6 0.06 79.69 PSEUDOMEMBRANOUS COLITIS | 4 0.04 79.73 PSEUDOMONAS INFECTION | 5 0.05 79.78 PSORIASIS | 4 0.04 79.82 PSORIATIC ARTHROPATHY | 3 0.03 79.85 PSYCHIATRIC DECOMPENSATION | 1 0.01 79.86 PSYCHIATRIC SYMPTOM | 2 0.02 79.88 PSYCHOMOTOR HYPERACTIVITY | 6 0.06 79.94 PSYCHOMOTOR SEIZURES | 1 0.01 79.95 PSYCHOMOTOR SKILLS IMPAIRED | 1 0.01 79.96 PSYCHOPATHIC PERSONALITY | 1 0.01 79.97 PSYCHOTIC DISORDER | 9 0.09 80.06 PULMONARY ALVEOLAR HAEMORRHAGE | 2 0.02 80.08 PULMONARY APLASIA | 1 0.01 80.09 PULMONARY ARTERIAL HYPERTENSION | 2 0.02 80.11 PULMONARY CONGESTION | 4 0.04 80.15 PULMONARY EMBOLISM | 35 0.35 80.50 PULMONARY FIBROSIS | 5 0.05 80.55 PULMONARY HAEMORRHAGE | 6 0.06 80.61 PULMONARY HYPERTENSION | 4 0.04 80.65 PULMONARY INFARCTION | 1 0.01 80.66 PULMONARY MASS | 1 0.01 80.67 PULMONARY OEDEMA | 6 0.06 80.73 PULMONARY THROMBOSIS | 2 0.02 80.75 PULSE ABSENT | 1 0.01 80.76 PULSE PRESSURE DECREASED | 1 0.01 80.77 PULSE VOLUME DECREASED | 1 0.01 80.78 PUNCTATE KERATITIS | 1 0.01 80.79 PURPLE GLOVE SYNDROME | 1 0.01 80.80 PURULENT DISCHARGE | 2 0.02 80.82 PYELOCALIECTASIS | 1 0.01 80.83 PYELONEPHRITIS | 6 0.06 80.89 PYODERMA GANGRENOSUM | 1 0.01 80.90 PYOTHORAX | 1 0.01 80.91 PYREXIA | 74 0.74 81.65 QUADRIPLEGIA | 1 0.01 81.66 QUALITY OF LIFE DECREASED | 2 0.02 81.68 RADIAL NERVE PALSY | 1 0.01 81.69 RADIATION SKIN INJURY | 1 0.01 81.70 RADICULITIS | 1 0.01 81.71 RADICULOPATHY | 1 0.01 81.72 RADIOTHERAPY | 1 0.01 81.73 RADIUS FRACTURE | 2 0.02 81.75 RASH | 68 0.68 82.43 RASH ERYTHEMATOUS | 6 0.06 82.49 RASH GENERALISED | 8 0.08 82.57 RASH MACULAR | 7 0.07 82.64 RASH MACULO-PAPULAR | 6 0.06 82.70 RASH NEONATAL | 1 0.01 82.71 RASH PAPULAR | 5 0.05 82.76 RASH PRURITIC | 9 0.09 82.85 RASH PUSTULAR | 1 0.01 82.86 RASH VESICULAR | 1 0.01 82.87 RAYNAUD'S PHENOMENON | 1 0.01 82.88 REACTION TO DRUG EXCIPIENTS | 2 0.02 82.90 READING DISORDER | 2 0.02 82.92 RECTAL HAEMORRHAGE | 10 0.10 83.02 RECTAL TENESMUS | 1 0.01 83.03 RECTAL ULCER HAEMORRHAGE | 1 0.01 83.04 RECURRENT CANCER | 1 0.01 83.05 RED BLOOD CELL COUNT ABNORMAL | 1 0.01 83.06 RED BLOOD CELL COUNT DECREASED | 10 0.10 83.16 RED BLOOD CELL SEDIMENTATION RATE INC.. | 2 0.02 83.18 RED BLOOD CELLS URINE POSITIVE | 1 0.01 83.19 RED CELL DISTRIBUTION WIDTH INCREASED | 3 0.03 83.22 REFLUX OESOPHAGITIS | 1 0.01 83.23 REGURGITATION | 1 0.01 83.24 REITER'S SYNDROME | 1 0.01 83.25 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 1 0.01 83.26 RENAL ANEURYSM | 1 0.01 83.27 RENAL ARTERY THROMBOSIS | 1 0.01 83.28 RENAL CANCER | 1 0.01 83.29 RENAL CELL CARCINOMA | 3 0.03 83.32 RENAL CELL CARCINOMA STAGE IV | 1 0.01 83.33 RENAL COLIC | 1 0.01 83.34 RENAL CYST | 3 0.03 83.37 RENAL DISORDER | 14 0.14 83.51 RENAL FAILURE | 29 0.29 83.80 RENAL FAILURE ACUTE | 41 0.41 84.21 RENAL FAILURE CHRONIC | 6 0.06 84.27 RENAL HYPOPLASIA | 1 0.01 84.28 RENAL IMPAIRMENT | 25 0.25 84.53 RENAL INFARCT | 1 0.01 84.54 RENAL PAPILLARY NECROSIS | 2 0.02 84.56 RENAL SALT-WASTING SYNDROME | 1 0.01 84.57 RENAL TRANSPLANT | 1 0.01 84.58 RENAL TUBULAR ACIDOSIS | 1 0.01 84.59 RENAL TUBULAR DISORDER | 2 0.02 84.61 RENAL TUBULAR NECROSIS | 1 0.01 84.62 REPRODUCTIVE TRACT DISORDER | 1 0.01 84.63 RESPIRATORY ARREST | 5 0.05 84.68 RESPIRATORY DEPRESSION | 4 0.04 84.72 RESPIRATORY DISORDER | 10 0.10 84.82 RESPIRATORY DISTRESS | 8 0.08 84.90 RESPIRATORY FAILURE | 23 0.23 85.13 RESPIRATORY RATE DECREASED | 1 0.01 85.14 RESPIRATORY RATE INCREASED | 1 0.01 85.15 RESPIRATORY TRACT CONGESTION | 1 0.01 85.16 RESPIRATORY TRACT INFECTION | 4 0.04 85.20 RESPIRATORY TRACT IRRITATION | 1 0.01 85.21 RESTLESS LEGS SYNDROME | 2 0.02 85.23 RESTLESSNESS | 13 0.13 85.36 RESUSCITATION | 1 0.01 85.37 RETCHING | 2 0.02 85.39 RETINAL HAEMORRHAGE | 5 0.05 85.44 RETINAL PIGMENT EPITHELIAL TEAR | 4 0.04 85.48 RETINAL VEIN OCCLUSION | 1 0.01 85.49 RETINOPATHY | 1 0.01 85.50 RETROGRADE EJACULATION | 1 0.01 85.51 RETROPERITONEAL HAEMORRHAGE | 1 0.01 85.52 RETROPERITONEAL LYMPHADENOPATHY | 1 0.01 85.53 REVERSIBLE POSTERIOR LEUKOENCEPHALOPA.. | 1 0.01 85.54 RHABDOMYOLYSIS | 11 0.11 85.65 RHEUMATOID ARTHRITIS | 5 0.05 85.70 RHINITIS ALLERGIC | 1 0.01 85.71 RHINORRHOEA | 3 0.03 85.74 RIB FRACTURE | 4 0.04 85.78 RIGHT VENTRICLE OUTFLOW TRACT OBSTRUC.. | 1 0.01 85.79 RIGHT VENTRICULAR DYSFUNCTION | 1 0.01 85.80 ROAD TRAFFIC ACCIDENT | 10 0.10 85.90 SALIVA ALTERED | 1 0.01 85.91 SALIVARY HYPERSECRETION | 2 0.02 85.93 SARCOIDOSIS | 1 0.01 85.94 SCAB | 2 0.02 85.96 SCAR | 7 0.07 86.03 SCHIZOPHRENIA | 1 0.01 86.04 SCIATICA | 1 0.01 86.05 SCLERAL DISCOLOURATION | 1 0.01 86.06 SCLERODERMA | 1 0.01 86.07 SCOTOMA | 1 0.01 86.08 SCRATCH | 4 0.04 86.12 SCREAMING | 4 0.04 86.16 SCROTAL SWELLING | 1 0.01 86.17 SCROTAL ULCER | 2 0.02 86.19 SEBORRHOEA | 1 0.01 86.20 SEBORRHOEIC DERMATITIS | 1 0.01 86.21 SECRETION DISCHARGE | 1 0.01 86.22 SEDATION | 4 0.04 86.26 SELECTIVE MUTISM | 1 0.01 86.27 SELF INJURIOUS BEHAVIOUR | 3 0.03 86.30 SENSATION OF BLOOD FLOW | 1 0.01 86.31 SENSATION OF FOREIGN BODY | 2 0.02 86.33 SENSATION OF HEAVINESS | 2 0.02 86.35 SENSATION OF PRESSURE | 1 0.01 86.36 SENSITIVITY OF TEETH | 2 0.02 86.38 SENSORY DISTURBANCE | 3 0.03 86.41 SENSORY LOSS | 1 0.01 86.42 SEPSIS | 19 0.19 86.61 SEPSIS NEONATAL | 1 0.01 86.62 SEPTIC SHOCK | 7 0.07 86.69 SEQUESTRECTOMY | 5 0.05 86.74 SEROTONIN SYNDROME | 3 0.03 86.77 SERUM FERRITIN DECREASED | 1 0.01 86.78 SERUM FERRITIN INCREASED | 6 0.06 86.84 SERUM SICKNESS | 4 0.04 86.88 SERUM SICKNESS-LIKE REACTION | 1 0.01 86.89 SEXUAL DYSFUNCTION | 2 0.02 86.91 SEXUALLY TRANSMITTED DISEASE | 1 0.01 86.92 SHOCK | 7 0.07 86.99 SHOCK HAEMORRHAGIC | 2 0.02 87.01 SHOCK HYPOGLYCAEMIC | 1 0.01 87.02 SICKLE CELL ANAEMIA WITH CRISIS | 1 0.01 87.03 SIGMOIDITIS | 1 0.01 87.04 SINUS ARRHYTHMIA | 1 0.01 87.05 SINUS BRADYCARDIA | 4 0.04 87.09 SINUS DISORDER | 1 0.01 87.10 SINUS TACHYCARDIA | 3 0.03 87.13 SINUSITIS | 10 0.10 87.23 SKIN BURNING SENSATION | 2 0.02 87.25 SKIN CANCER | 4 0.04 87.29 SKIN CHAPPED | 2 0.02 87.31 SKIN DISCOLOURATION | 8 0.08 87.39 SKIN DISORDER | 4 0.04 87.43 SKIN EXFOLIATION | 11 0.11 87.54 SKIN FIBROSIS | 2 0.02 87.56 SKIN FISSURES | 2 0.02 87.58 SKIN HYPERTROPHY | 7 0.07 87.65 SKIN INDURATION | 3 0.03 87.68 SKIN INFECTION | 1 0.01 87.69 SKIN IRRITATION | 3 0.03 87.72 SKIN LACERATION | 2 0.02 87.74 SKIN LESION | 4 0.04 87.78 SKIN MASS | 1 0.01 87.79 SKIN NECROSIS | 1 0.01 87.80 SKIN NEOPLASM EXCISION | 1 0.01 87.81 SKIN OEDEMA | 1 0.01 87.82 SKIN PLAQUE | 4 0.04 87.86 SKIN REACTION | 1 0.01 87.87 SKIN SWELLING | 1 0.01 87.88 SKIN TEST NEGATIVE | 2 0.02 87.90 SKIN TIGHTNESS | 4 0.04 87.94 SKIN ULCER | 7 0.07 88.01 SKULL FRACTURE | 1 0.01 88.02 SLEEP APNOEA SYNDROME | 4 0.04 88.06 SLEEP DISORDER | 2 0.02 88.08 SLEEP DISORDER DUE TO GENERAL MEDICAL.. | 1 0.01 88.09 SLEEP TALKING | 1 0.01 88.10 SLEEP TERROR | 3 0.03 88.13 SMALL FOR DATES BABY | 1 0.01 88.14 SMALL INTESTINAL OBSTRUCTION | 2 0.02 88.16 SMALL INTESTINAL RESECTION | 1 0.01 88.17 SNEEZING | 3 0.03 88.20 SNORING | 1 0.01 88.21 SOCIAL PHOBIA | 1 0.01 88.22 SOFT TISSUE DISORDER | 1 0.01 88.23 SOFT TISSUE NECROSIS | 2 0.02 88.25 SOLITARY KIDNEY | 1 0.01 88.26 SOMNAMBULISM | 4 0.04 88.30 SOMNOLENCE | 33 0.33 88.63 SOPOR | 1 0.01 88.64 SPEECH DISORDER | 14 0.14 88.78 SPINAL COLUMN STENOSIS | 1 0.01 88.79 SPINAL COMPRESSION FRACTURE | 1 0.01 88.80 SPINAL CORD DISORDER | 1 0.01 88.81 SPINAL DECOMPRESSION | 1 0.01 88.82 SPINAL DISORDER | 3 0.03 88.85 SPINAL FRACTURE | 3 0.03 88.88 SPINAL FUSION SURGERY | 2 0.02 88.90 SPINAL LAMINECTOMY | 1 0.01 88.91 SPINAL OPERATION | 1 0.01 88.92 SPINAL OSTEOARTHRITIS | 1 0.01 88.93 SPLEEN DISORDER | 2 0.02 88.95 SPLENOMEGALY | 1 0.01 88.96 SPONDYLOLISTHESIS | 1 0.01 88.97 SPUTUM CULTURE POSITIVE | 1 0.01 88.98 SQUAMOUS CELL CARCINOMA | 3 0.03 89.01 SQUAMOUS CELL CARCINOMA OF SKIN | 1 0.01 89.02 STAPHYLOCOCCAL ABSCESS | 1 0.01 89.03 STAPHYLOCOCCAL BACTERAEMIA | 3 0.03 89.06 STAPHYLOCOCCAL INFECTION | 7 0.07 89.13 STAPHYLOCOCCAL SEPSIS | 1 0.01 89.14 STARVATION | 1 0.01 89.15 STATUS ASTHMATICUS | 2 0.02 89.17 STATUS EPILEPTICUS | 1 0.01 89.18 STENOTROPHOMONAS SEPSIS | 1 0.01 89.19 STENT PLACEMENT | 4 0.04 89.23 STERNAL FRACTURE | 1 0.01 89.24 STEVENS-JOHNSON SYNDROME | 5 0.05 89.29 STILL'S DISEASE ADULT ONSET | 1 0.01 89.30 STILLBIRTH | 3 0.03 89.33 STOMATITIS | 12 0.12 89.45 STRESS | 7 0.07 89.52 STRESS AT WORK | 1 0.01 89.53 STRESS FRACTURE | 3 0.03 89.56 STRESS URINARY INCONTINENCE | 1 0.01 89.57 STUBBORNNESS | 1 0.01 89.58 STUPOR | 2 0.02 89.60 SUBARACHNOID HAEMORRHAGE | 1 0.01 89.61 SUBCUTANEOUS ABSCESS | 1 0.01 89.62 SUBCUTANEOUS HAEMATOMA | 1 0.01 89.63 SUBDURAL HAEMATOMA | 2 0.02 89.65 SUBILEUS | 3 0.03 89.68 SUBSTANCE ABUSE | 1 0.01 89.69 SUDDEN DEATH | 3 0.03 89.72 SUICIDAL IDEATION | 23 0.23 89.95 SUICIDE ATTEMPT | 8 0.08 90.03 SUPRAVENTRICULAR TACHYARRHYTHMIA | 1 0.01 90.04 SUPRAVENTRICULAR TACHYCARDIA | 6 0.06 90.10 SURGERY | 15 0.15 90.25 SWEAT DISCOLOURATION | 1 0.01 90.26 SWEAT GLAND DISORDER | 1 0.01 90.27 SWELLING | 12 0.12 90.39 SWELLING FACE | 12 0.12 90.51 SWOLLEN TONGUE | 11 0.11 90.62 SYNCOPE | 28 0.28 90.90 SYSTEMIC CANDIDA | 1 0.01 90.91 SYSTEMIC LUPUS ERYTHEMATOSUS | 3 0.03 90.94 SYSTEMIC LUPUS ERYTHEMATOSUS RASH | 1 0.01 90.95 T-LYMPHOCYTE COUNT DECREASED | 1 0.01 90.96 TACHYARRHYTHMIA | 1 0.01 90.97 TACHYCARDIA | 13 0.13 91.10 TACHYPHRENIA | 1 0.01 91.11 TACHYPNOEA | 4 0.04 91.15 TARDIVE DYSKINESIA | 3 0.03 91.18 TELANGIECTASIA | 1 0.01 91.19 TEMPOROMANDIBULAR JOINT SYNDROME | 3 0.03 91.22 TENDERNESS | 1 0.01 91.23 TENDON DISORDER | 2 0.02 91.25 TENDON PAIN | 1 0.01 91.26 TENDON RUPTURE | 5 0.05 91.31 TENDONITIS | 5 0.05 91.36 TENOSYNOVITIS STENOSANS | 1 0.01 91.37 TETHERED CORD SYNDROME | 1 0.01 91.38 THERAPEUTIC AGENT TOXICITY | 4 0.04 91.42 THERAPEUTIC PROCEDURE | 1 0.01 91.43 THERAPEUTIC RESPONSE DECREASED | 12 0.12 91.55 THERAPEUTIC RESPONSE UNEXPECTED | 1 0.01 91.56 THERMAL BURN | 3 0.03 91.59 THERMOHYPOAESTHESIA | 1 0.01 91.60 THINKING ABNORMAL | 4 0.04 91.64 THIRST | 7 0.07 91.71 THROAT CANCER | 1 0.01 91.72 THROAT IRRITATION | 6 0.06 91.78 THROAT TIGHTNESS | 6 0.06 91.84 THROMBOCYTOPENIA | 23 0.23 92.07 THROMBOCYTOPENIC PURPURA | 3 0.03 92.10 THROMBOCYTOSIS | 1 0.01 92.11 THROMBOSIS | 18 0.18 92.29 THROMBOSIS IN DEVICE | 1 0.01 92.30 THROMBOTIC MICROANGIOPATHY | 1 0.01 92.31 THYROID CANCER | 3 0.03 92.34 THYROID CANCER METASTATIC | 1 0.01 92.35 THYROID DISORDER | 6 0.06 92.41 THYROIDITIS | 1 0.01 92.42 THYROIDITIS SUBACUTE | 1 0.01 92.43 TIBIA FRACTURE | 3 0.03 92.46 TIC | 5 0.05 92.51 TINEA INFECTION | 1 0.01 92.52 TINEA PEDIS | 2 0.02 92.54 TINNITUS | 7 0.07 92.61 TOBACCO USER | 1 0.01 92.62 TOE AMPUTATION | 1 0.01 92.63 TONGUE BITING | 1 0.01 92.64 TONGUE COATED | 1 0.01 92.65 TONGUE DISCOLOURATION | 1 0.01 92.66 TONGUE DISORDER | 1 0.01 92.67 TONGUE DRY | 2 0.02 92.69 TONGUE PARALYSIS | 1 0.01 92.70 TONGUE SPASM | 1 0.01 92.71 TONGUE ULCERATION | 1 0.01 92.72 TONIC CONVULSION | 1 0.01 92.73 TONSILLITIS | 3 0.03 92.76 TOOTH ABSCESS | 1 0.01 92.77 TOOTH DEPOSIT | 1 0.01 92.78 TOOTH DISCOLOURATION | 4 0.04 92.82 TOOTH DISORDER | 4 0.04 92.86 TOOTH EROSION | 1 0.01 92.87 TOOTH EXTRACTION | 4 0.04 92.91 TOOTH FRACTURE | 2 0.02 92.93 TOOTH LOSS | 3 0.03 92.96 TOOTH RESORPTION | 1 0.01 92.97 TOOTHACHE | 2 0.02 92.99 TORSADE DE POINTES | 2 0.02 93.01 TOTAL CHOLESTEROL/HDL RATIO INCREASED | 1 0.01 93.02 TOURETTE'S DISORDER | 2 0.02 93.04 TOXIC EPIDERMAL NECROLYSIS | 3 0.03 93.07 TOXIC NEUROPATHY | 1 0.01 93.08 TOXIC SKIN ERUPTION | 2 0.02 93.10 TRACHEOBRONCHITIS | 1 0.01 93.11 TRANSAMINASES INCREASED | 6 0.06 93.17 TRANSFUSION | 1 0.01 93.18 TRANSIENT ISCHAEMIC ATTACK | 8 0.08 93.26 TRANSMISSION OF AN INFECTIOUS AGENT V.. | 26 0.26 93.52 TRANSMYOCARDIAL REVASCULARISATION | 1 0.01 93.53 TRANSPLANT FAILURE | 1 0.01 93.54 TRANSPLANT REJECTION | 2 0.02 93.56 TRANSPOSITION OF THE GREAT VESSELS | 1 0.01 93.57 TRAUMATIC HAEMORRHAGE | 1 0.01 93.58 TREATMENT NONCOMPLIANCE | 7 0.07 93.65 TREMOR | 23 0.23 93.88 TRI-IODOTHYRONINE INCREASED | 1 0.01 93.89 TRICHORRHEXIS | 2 0.02 93.91 TRIGEMINAL NEURALGIA | 3 0.03 93.94 TRIGGER FINGER | 1 0.01 93.95 TRISMUS | 4 0.04 93.99 TUBERCULIN TEST POSITIVE | 2 0.02 94.01 TUBERCULOSIS | 2 0.02 94.03 TUBERCULOUS PLEURISY | 1 0.01 94.04 TUBULOINTERSTITIAL NEPHRITIS | 3 0.03 94.07 TUMOUR HAEMORRHAGE | 1 0.01 94.08 TUMOUR LYSIS SYNDROME | 1 0.01 94.09 TUMOUR MARKER INCREASED | 1 0.01 94.10 TUMOUR PAIN | 1 0.01 94.11 TYPE 1 DIABETES MELLITUS | 3 0.03 94.14 TYPE 2 DIABETES MELLITUS | 7 0.07 94.21 TYPE III IMMUNE COMPLEX MEDIATED REAC.. | 1 0.01 94.22 UBIQUINONE DECREASED | 2 0.02 94.24 ULCER | 3 0.03 94.27 ULCER HAEMORRHAGE | 2 0.02 94.29 ULCERATIVE KERATITIS | 1 0.01 94.30 ULTRAFILTRATION FAILURE | 1 0.01 94.31 ULTRASOUND PELVIS ABNORMAL | 3 0.03 94.34 UNEVALUABLE EVENT | 11 0.11 94.45 UNINTENDED PREGNANCY | 2 0.02 94.47 UNRESPONSIVE TO STIMULI | 8 0.08 94.55 UPPER GASTROINTESTINAL HAEMORRHAGE | 4 0.04 94.59 UPPER LIMB FRACTURE | 5 0.05 94.64 UPPER RESPIRATORY TRACT INFECTION | 6 0.06 94.70 URETERAL DISORDER | 2 0.02 94.72 URETERIC OBSTRUCTION | 2 0.02 94.74 URETERIC STENOSIS | 1 0.01 94.75 URETHRAL HAEMORRHAGE | 1 0.01 94.76 URINARY BLADDER HAEMORRHAGE | 1 0.01 94.77 URINARY HESITATION | 1 0.01 94.78 URINARY INCONTINENCE | 4 0.04 94.82 URINARY RETENTION | 7 0.07 94.89 URINARY TRACT DISORDER | 2 0.02 94.91 URINARY TRACT INFECTION | 38 0.38 95.29 URINARY TRACT INFECTION ENTEROCOCCAL | 1 0.01 95.30 URINE ABNORMALITY | 1 0.01 95.31 URINE COLOUR ABNORMAL | 2 0.02 95.33 URINE COPPER DECREASED | 1 0.01 95.34 URINE HUMAN CHORIONIC GONADOTROPIN PO.. | 1 0.01 95.35 URINE OUTPUT DECREASED | 3 0.03 95.38 URINE OUTPUT INCREASED | 1 0.01 95.39 URINOMA | 1 0.01 95.40 UROSEPSIS | 2 0.02 95.42 URTICARIA | 28 0.28 95.70 UTERINE DISORDER | 1 0.01 95.71 UTERINE HAEMORRHAGE | 2 0.02 95.73 UTERINE LEIOMYOMA | 2 0.02 95.75 UTERINE PERFORATION | 5 0.05 95.80 UTERINE POLYP | 1 0.01 95.81 UVEITIS | 2 0.02 95.83 UVULITIS | 1 0.01 95.84 VAGINAL DISCHARGE | 1 0.01 95.85 VAGINAL HAEMORRHAGE | 18 0.18 96.03 VAGINAL INFECTION | 1 0.01 96.04 VANISHING BILE DUCT SYNDROME | 1 0.01 96.05 VARICES OESOPHAGEAL | 2 0.02 96.07 VASCULAR GRAFT | 5 0.05 96.12 VASCULAR GRAFT THROMBOSIS | 1 0.01 96.13 VASCULAR OCCLUSION | 1 0.01 96.14 VASCULAR PURPURA | 1 0.01 96.15 VASCULITIS | 2 0.02 96.17 VASODILATATION | 2 0.02 96.19 VENOOCCLUSIVE LIVER DISEASE | 2 0.02 96.21 VENTRICULAR FIBRILLATION | 3 0.03 96.24 VENTRICULAR SEPTAL DEFECT | 1 0.01 96.25 VENTRICULAR TACHYCARDIA | 3 0.03 96.28 VERTEBRAL COLUMN MASS | 1 0.01 96.29 VERTEBROPLASTY | 1 0.01 96.30 VERTIGO | 10 0.10 96.40 VERTIGO POSITIONAL | 1 0.01 96.41 VESSEL PERFORATION | 1 0.01 96.42 VESTIBULAR DISORDER | 1 0.01 96.43 VIOLENCE-RELATED SYMPTOM | 1 0.01 96.44 VIRAEMIA | 1 0.01 96.45 VIRAL INFECTION | 3 0.03 96.48 VIRAL TEST POSITIVE | 2 0.02 96.50 VISION BLURRED | 28 0.28 96.78 VISUAL ACUITY REDUCED | 17 0.17 96.95 VISUAL BRIGHTNESS | 1 0.01 96.96 VISUAL FIELD DEFECT | 1 0.01 96.97 VISUAL IMPAIRMENT | 21 0.21 97.18 VITAMIN B12 DECREASED | 1 0.01 97.19 VITAMIN D DEFICIENCY | 1 0.01 97.20 VITREOUS DETACHMENT | 1 0.01 97.21 VITREOUS DISORDER | 1 0.01 97.22 VITREOUS FLOATERS | 2 0.02 97.24 VITREOUS HAEMORRHAGE | 3 0.03 97.27 VOCAL CORD PARALYSIS | 1 0.01 97.28 VOLVULUS | 1 0.01 97.29 VOMITING | 112 1.12 98.41 VOMITING IN PREGNANCY | 1 0.01 98.42 VULVOVAGINAL DISCOMFORT | 1 0.01 98.43 VULVOVAGINAL MYCOTIC INFECTION | 3 0.03 98.46 VULVOVAGINITIS | 1 0.01 98.47 WALKING AID USER | 1 0.01 98.48 WALKING DISABILITY | 1 0.01 98.49 WEGENER'S GRANULOMATOSIS | 1 0.01 98.50 WEIGHT DECREASED | 31 0.31 98.81 WEIGHT FLUCTUATION | 1 0.01 98.82 WEIGHT INCREASED | 28 0.28 99.10 WHEELCHAIR USER | 2 0.02 99.12 WHEEZING | 8 0.08 99.20 WHITE BLOOD CELL COUNT ABNORMAL | 1 0.01 99.21 WHITE BLOOD CELL COUNT DECREASED | 23 0.23 99.44 WHITE BLOOD CELL COUNT INCREASED | 15 0.15 99.59 WITHDRAWAL BLEED | 1 0.01 99.60 WITHDRAWAL SYNDROME | 8 0.08 99.68 WOUND | 1 0.01 99.69 WOUND DECOMPOSITION | 1 0.01 99.70 WOUND DEHISCENCE | 2 0.02 99.72 WOUND DRAINAGE | 1 0.01 99.73 WOUND INFECTION | 1 0.01 99.74 WOUND INFECTION PSEUDOMONAS | 1 0.01 99.75 WOUND TREATMENT | 1 0.01 99.76 WRIST FRACTURE | 2 0.02 99.78 WRONG DRUG ADMINISTERED | 4 0.04 99.82 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 15 0.15 99.97 YAWNING | 2 0.02 99.99 YELLOW SKIN | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015